No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1egyA, 1.0000, 0.00, 1.000, 403, 403, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
2, 1oxaA, 0.9972, 0.39, 1.000, 403, 403, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
3, 1eupA, 0.9965, 0.44, 1.000, 403, 403, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
4, 1z8pA, 0.9958, 0.47, 0.978, 403, 403, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
5, 1jioA, 0.9956, 0.53, 0.980, 403, 403, P450ERYF/6DEB
6, 1jipA, 0.9954, 0.50, 0.978, 403, 403, P450ERYF(A245S)/KETOCONAZOLE
7, 1z8qA, 0.9947, 0.53, 0.978, 403, 403, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
8, 1jinA, 0.9947, 0.54, 1.000, 403, 403, P450ERYF/KETOCONAZOLE
9, 1z8oA, 0.9939, 0.44, 0.983, 402, 402, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
10, 4umzA, 0.9131, 2.14, 0.469, 396, 390, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
11, 6gk5A, 0.9127, 2.32, 0.345, 403, 397, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP267B1 FROM SORANGIUM CELLULOSUM SO CE56 
12, 6gk6A, 0.9124, 2.33, 0.345, 403, 397, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYTOCHROME P450 CYP267B1 IN COMPLEX WITH MYRISTIC ACID 
13, 2vz7A, 0.9119, 2.17, 0.469, 396, 390, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
14, 2wi9A, 0.9117, 2.08, 0.468, 396, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
15, 2whwA, 0.9110, 2.08, 0.468, 396, 389, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
16, 4umzB, 0.9105, 2.15, 0.470, 395, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
17, 4bf4D, 0.9104, 2.18, 0.468, 397, 389, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
18, 2vzmA, 0.9100, 2.06, 0.469, 395, 388, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
19, 4bf4O, 0.9094, 2.09, 0.472, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
20, 4b7dB, 0.9093, 2.07, 0.470, 393, 387, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
21, 4bf4M, 0.9087, 2.12, 0.469, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
22, 4bf4A, 0.9086, 2.14, 0.469, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
23, 3zpiB, 0.9085, 2.15, 0.468, 396, 389, PIKC D50N MUTANT IN P21 SPACE GROUP
24, 4jbtB, 0.9079, 2.54, 0.335, 407, 397, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
25, 4bf4B, 0.9077, 2.15, 0.469, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
26, 4jbtA, 0.9076, 2.55, 0.335, 407, 397, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
27, 4j6cB, 0.9076, 2.55, 0.335, 406, 397, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
28, 4bf4N, 0.9076, 2.14, 0.466, 397, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
29, 4j6cA, 0.9075, 2.55, 0.335, 407, 397, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
30, 4bf4G, 0.9074, 2.16, 0.469, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
31, 3zk5B, 0.9071, 2.08, 0.470, 394, 387, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
32, 2vzmB, 0.9070, 2.08, 0.470, 394, 387, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
33, 4bf4L, 0.9069, 2.07, 0.470, 397, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
34, 4bf4H, 0.9069, 2.05, 0.470, 396, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
35, 4bf4I, 0.9068, 2.18, 0.469, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
36, 4j6dB, 0.9067, 2.52, 0.333, 406, 396, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
37, 2wi9B, 0.9067, 2.15, 0.461, 394, 388, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
38, 2c7xA, 0.9067, 2.25, 0.470, 396, 389, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
39, 4bf4P, 0.9064, 2.08, 0.470, 396, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
40, 4bf4J, 0.9061, 2.08, 0.468, 397, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
41, 4bf4F, 0.9061, 2.19, 0.469, 396, 388, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
42, 4j6dA, 0.9060, 2.53, 0.336, 406, 396, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
43, 2vz7B, 0.9060, 2.05, 0.469, 393, 386, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
44, 4bf4E, 0.9056, 2.08, 0.473, 397, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
45, 4bf4K, 0.9054, 2.10, 0.473, 397, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
46, 3zpiA, 0.9053, 2.19, 0.466, 396, 388, PIKC D50N MUTANT IN P21 SPACE GROUP
47, 3zk5A, 0.9051, 2.19, 0.469, 397, 388, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
48, 2c6hA, 0.9051, 2.08, 0.469, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
49, 2c6hB, 0.9049, 2.13, 0.468, 394, 387, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
50, 4b7dA, 0.9048, 2.06, 0.472, 393, 386, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
51, 2whwB, 0.9047, 2.07, 0.469, 393, 386, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
52, 4j6bB, 0.9045, 2.53, 0.334, 405, 395, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
53, 4j6bA, 0.9044, 2.53, 0.334, 405, 395, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
54, 4bf4C, 0.9042, 2.12, 0.468, 396, 387, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
55, 4b7sB, 0.9041, 2.09, 0.469, 393, 386, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
56, 4b7sA, 0.9029, 2.13, 0.470, 397, 387, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
57, 2ca0A, 0.9028, 2.11, 0.469, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
58, 2bvjA, 0.9028, 2.04, 0.472, 394, 386, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
59, 2cd8B, 0.9016, 2.16, 0.472, 392, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
60, 5gweC, 0.9002, 2.39, 0.292, 405, 390, CYTOCHROME P450 CREJ
61, 3abaA, 0.8998, 2.41, 0.368, 397, 391, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
62, 2ca0B, 0.8995, 2.16, 0.469, 393, 386, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
63, 4mm0B, 0.8994, 2.21, 0.385, 394, 387, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
64, 5gweA, 0.8992, 2.48, 0.294, 405, 391, CYTOCHROME P450 CREJ
65, 2cd8A, 0.8982, 2.19, 0.473, 391, 385, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
66, 4mm0A, 0.8970, 2.26, 0.385, 392, 387, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
67, 5cjeA, 0.8969, 2.16, 0.474, 390, 384, STRUCTURE OF CYP107L2
68, 3a50A, 0.8969, 2.54, 0.424, 402, 389, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
69, 3a51A, 0.8967, 2.54, 0.424, 402, 389, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
70, 3cv9A, 0.8962, 2.47, 0.362, 401, 392, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
71, 5xjnA, 0.8960, 2.37, 0.294, 403, 388, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
72, 4yzrA, 0.8960, 2.01, 0.378, 388, 386, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
73, 5gweD, 0.8958, 2.35, 0.294, 403, 388, CYTOCHROME P450 CREJ
74, 3a4zA, 0.8958, 2.48, 0.425, 402, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
75, 5x7eA, 0.8946, 2.46, 0.358, 404, 391, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
76, 3a4zD, 0.8944, 2.57, 0.425, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
77, 3a51D, 0.8943, 2.57, 0.425, 402, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
78, 3a50D, 0.8935, 2.49, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
79, 3cv8A, 0.8932, 2.46, 0.355, 402, 391, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
80, 2zbyA, 0.8932, 2.40, 0.364, 400, 390, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
81, 3a50C, 0.8930, 2.54, 0.423, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
82, 3a4zE, 0.8930, 2.49, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
83, 2zbzA, 0.8929, 2.47, 0.363, 404, 391, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
84, 3a4zC, 0.8928, 2.55, 0.423, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
85, 3a51C, 0.8926, 2.55, 0.425, 401, 388, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
86, 2z3uA, 0.8924, 2.81, 0.323, 411, 399, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
87, 3a51B, 0.8921, 2.49, 0.424, 402, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
88, 3a50B, 0.8921, 2.49, 0.424, 402, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
89, 3a50E, 0.8920, 2.50, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
90, 3a51E, 0.8919, 2.50, 0.424, 401, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
91, 3a4zB, 0.8918, 2.49, 0.424, 402, 387, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
92, 3a1lA, 0.8904, 2.89, 0.326, 411, 399, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
93, 2zbxA, 0.8900, 2.41, 0.361, 399, 388, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
94, 5cweB, 0.8894, 2.27, 0.477, 393, 384, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
95, 3vrmA, 0.8892, 2.59, 0.422, 402, 386, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
96, 5cweA, 0.8883, 2.31, 0.479, 393, 384, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
97, 5gnmB, 0.8880, 2.59, 0.429, 399, 389, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
98, 5foiA, 0.8874, 2.29, 0.328, 389, 384, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
99, 2wm4A, 0.8874, 2.31, 0.290, 426, 386, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
100, 1gwiB, 0.8873, 2.68, 0.360, 400, 392, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
101, 4ubsA, 0.8866, 2.48, 0.355, 393, 389, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
102, 5gnmA, 0.8864, 2.63, 0.429, 399, 389, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
103, 5foiB, 0.8858, 2.28, 0.329, 388, 383, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
104, 1odoA, 0.8857, 2.57, 0.342, 395, 389, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
105, 6giiA, 0.8847, 2.56, 0.256, 416, 390, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
106, 2xkrA, 0.8844, 2.14, 0.307, 395, 381, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
107, 4pxhE, 0.8840, 2.63, 0.257, 407, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
108, 3wvsA, 0.8835, 2.47, 0.359, 393, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
109, 3a4hA, 0.8834, 2.70, 0.427, 400, 389, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
110, 4pxhA, 0.8827, 2.66, 0.257, 417, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
111, 4pxhC, 0.8823, 2.67, 0.257, 409, 389, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
112, 5fygA, 0.8822, 2.42, 0.229, 422, 385, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
113, 3ejbH, 0.8820, 2.23, 0.344, 387, 381, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
114, 3ejbD, 0.8816, 2.21, 0.342, 386, 380, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
115, 3ejdD, 0.8815, 2.28, 0.345, 385, 380, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
116, 1xqdA, 0.8812, 2.54, 0.298, 399, 389, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
117, 2bvjB, 0.8808, 2.20, 0.468, 391, 378, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
118, 3bujA, 0.8807, 2.60, 0.301, 397, 389, CRYSTAL STRUCTURE OF CALO2
119, 3ejeD, 0.8805, 2.20, 0.346, 385, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
120, 1pkfA, 0.8804, 2.68, 0.283, 403, 392, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
121, 5fygB, 0.8800, 2.43, 0.226, 419, 385, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
122, 5fyfA, 0.8799, 2.40, 0.229, 420, 384, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
123, 5gnmD, 0.8786, 2.74, 0.427, 401, 389, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
124, 2wm5A, 0.8786, 2.47, 0.281, 425, 385, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
125, 5gnmC, 0.8782, 2.78, 0.429, 401, 389, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
126, 5gnlA, 0.8780, 2.40, 0.399, 395, 381, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
127, 1gwiA, 0.8780, 2.81, 0.347, 402, 389, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
128, 3ejdB, 0.8778, 2.14, 0.345, 382, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
129, 1q5dA, 0.8776, 2.65, 0.282, 401, 390, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
130, 3a4gA, 0.8772, 2.45, 0.402, 395, 381, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
131, 3ejeH, 0.8764, 2.19, 0.347, 383, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
132, 1q5eA, 0.8762, 2.75, 0.281, 404, 392, SUBSTRATE-FREE CYTOCHROME P450EPOK
133, 6bldA, 0.8759, 2.37, 0.276, 414, 384, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
134, 3bdzA, 0.8755, 2.40, 0.257, 397, 382, THE ROLE OF ASN 242 IN P450CIN
135, 3ejdH, 0.8754, 2.23, 0.347, 382, 377, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
136, 3be0A, 0.8754, 2.38, 0.257, 397, 382, THE ROLE OF ASN 242 IN P450CIN
137, 5l92A, 0.8753, 2.20, 0.309, 386, 376, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
138, 4l77B, 0.8753, 2.40, 0.257, 397, 382, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
139, 3bdzB, 0.8753, 2.40, 0.257, 397, 382, THE ROLE OF ASN 242 IN P450CIN
140, 4lhtA, 0.8752, 2.40, 0.254, 396, 382, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
141, 3ejdF, 0.8749, 2.15, 0.346, 381, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
142, 3be0B, 0.8748, 2.38, 0.257, 397, 382, THE ROLE OF ASN 242 IN P450CIN
143, 4fyzA, 0.8747, 2.41, 0.254, 397, 382, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
144, 4lhtB, 0.8744, 2.41, 0.254, 396, 382, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
145, 4l6gA, 0.8744, 2.40, 0.254, 397, 382, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
146, 5gweB, 0.8743, 2.47, 0.291, 396, 381, CYTOCHROME P450 CREJ
147, 4fyzB, 0.8738, 2.42, 0.254, 397, 382, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
148, 5l94A, 0.8736, 2.27, 0.309, 385, 376, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
149, 3ejeF, 0.8735, 2.13, 0.347, 380, 375, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
150, 3wecA, 0.8732, 2.74, 0.260, 401, 389, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
151, 4l77A, 0.8730, 2.40, 0.257, 396, 381, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
152, 3ejbB, 0.8727, 2.20, 0.341, 380, 375, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
153, 1t2bB, 0.8727, 2.44, 0.254, 397, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
154, 4l6gB, 0.8726, 2.44, 0.254, 397, 382, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
155, 4fmxB, 0.8726, 2.44, 0.254, 397, 382, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
156, 4fmxA, 0.8724, 2.44, 0.254, 397, 382, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
157, 4triB, 0.8723, 2.37, 0.297, 400, 381, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
158, 2yooA, 0.8723, 2.38, 0.297, 396, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
159, 5mnvC, 0.8722, 2.67, 0.357, 396, 389, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
160, 1phfA, 0.8720, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
161, 1gebA, 0.8720, 2.34, 0.218, 405, 381, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
162, 2h7qA, 0.8719, 2.34, 0.218, 405, 381, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
163, 1phbA, 0.8719, 2.34, 0.218, 405, 381, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
164, 1t2bA, 0.8718, 2.45, 0.254, 397, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
165, 1phcA, 0.8718, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
166, 6cppA, 0.8717, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
167, 2x5wA, 0.8717, 2.82, 0.271, 409, 391, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
168, 1phaA, 0.8717, 2.34, 0.218, 405, 381, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
169, 1iwkA, 0.8716, 2.35, 0.213, 405, 381, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
170, 1cp4A, 0.8716, 2.34, 0.218, 405, 381, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
171, 4l49A, 0.8715, 2.35, 0.218, 405, 381, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
172, 2z97A, 0.8715, 2.35, 0.220, 405, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
173, 1re9A, 0.8715, 2.39, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
174, 1gemA, 0.8715, 2.35, 0.218, 405, 381, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
175, 1pheA, 0.8714, 2.34, 0.218, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
176, 2gr6A, 0.8713, 2.34, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
177, 1gjmA, 0.8713, 2.33, 0.220, 405, 381, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
178, 4cppA, 0.8712, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
179, 2ferA, 0.8712, 2.36, 0.218, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
180, 1phdA, 0.8712, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
181, 4l4aA, 0.8711, 2.35, 0.220, 405, 381, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
182, 8cppA, 0.8710, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
183, 1iwjA, 0.8710, 2.36, 0.218, 405, 381, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
184, 1iwiA, 0.8710, 2.35, 0.218, 405, 381, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
185, 7cppA, 0.8709, 2.34, 0.218, 405, 381, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
186, 3cppA, 0.8709, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
187, 2cp4A, 0.8709, 2.35, 0.220, 405, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
188, 1t87A, 0.8709, 2.35, 0.218, 407, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
189, 1phgA, 0.8709, 2.35, 0.218, 405, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
190, 3cp4A, 0.8708, 2.36, 0.215, 405, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
191, 2yooD, 0.8708, 2.41, 0.297, 394, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
192, 1c8jA, 0.8708, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
193, 4triA, 0.8707, 2.41, 0.294, 401, 381, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
194, 4l4eA, 0.8707, 2.36, 0.220, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
195, 2wioA, 0.8707, 2.38, 0.324, 393, 377, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
196, 2cppA, 0.8707, 2.35, 0.218, 405, 381, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
197, 1t86A, 0.8707, 2.35, 0.218, 406, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
198, 1p7rA, 0.8707, 2.36, 0.223, 407, 381, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
199, 1nooA, 0.8707, 2.36, 0.218, 405, 381, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
200, 5cppA, 0.8706, 2.36, 0.218, 405, 381, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
201, 4ek1B, 0.8706, 2.36, 0.218, 404, 381, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
202, 4cp4A, 0.8706, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
203, 1uyuB, 0.8706, 2.36, 0.218, 405, 381, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
204, 1p2yA, 0.8706, 2.36, 0.220, 407, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
205, 1dz8B, 0.8706, 2.36, 0.218, 405, 381, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
206, 3wrlA, 0.8705, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
207, 3wrhA, 0.8705, 2.36, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
208, 3p6pA, 0.8705, 2.40, 0.220, 407, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
209, 3oiaA, 0.8705, 2.39, 0.220, 405, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
210, 2gqxA, 0.8705, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
211, 1yrdA, 0.8705, 2.36, 0.223, 405, 381, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
212, 1lwlA, 0.8705, 2.39, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
213, 1j51A, 0.8705, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
214, 1gekA, 0.8705, 2.37, 0.218, 406, 381, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
215, 5cp4A, 0.8704, 2.37, 0.218, 406, 381, CRYOGENIC STRUCTURE OF P450CAM
216, 3wrjA, 0.8704, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450CAM
217, 3p6oA, 0.8704, 2.40, 0.220, 405, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
218, 3p6mA, 0.8704, 2.39, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
219, 2zuhA, 0.8704, 2.36, 0.223, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
220, 1akdA, 0.8704, 2.39, 0.217, 405, 382, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
221, 2a1oA, 0.8703, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
222, 1t88A, 0.8703, 2.36, 0.218, 407, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
223, 1mpwA, 0.8703, 2.36, 0.220, 405, 381, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
224, 1dz9B, 0.8703, 2.36, 0.218, 405, 381, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
225, 1dz8A, 0.8703, 2.37, 0.223, 404, 381, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
226, 1dz4B, 0.8703, 2.36, 0.218, 405, 381, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
227, 5kdbA, 0.8702, 2.51, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
228, 4l4bA, 0.8702, 2.37, 0.220, 405, 381, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
229, 3r9cA, 0.8702, 2.89, 0.324, 400, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
230, 3fwgB, 0.8702, 2.37, 0.218, 405, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
231, 2zujA, 0.8702, 2.36, 0.223, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
232, 1uyuA, 0.8702, 2.37, 0.220, 404, 381, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
233, 1o76B, 0.8702, 2.36, 0.218, 405, 381, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
234, 1j51C, 0.8702, 2.36, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
235, 1dz9A, 0.8702, 2.37, 0.223, 404, 381, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
236, 5u6tA, 0.8701, 2.51, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
237, 4l4fA, 0.8701, 2.37, 0.220, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
238, 4l4cA, 0.8701, 2.37, 0.220, 405, 381, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
239, 3wrjE, 0.8701, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450CAM
240, 2zwuA, 0.8701, 2.36, 0.223, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
241, 2zaxA, 0.8701, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
242, 2xfhA, 0.8701, 2.40, 0.325, 394, 379, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
243, 2gr6B, 0.8701, 2.37, 0.226, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
244, 2feuB, 0.8701, 2.37, 0.218, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
245, 2a1nA, 0.8701, 2.37, 0.218, 407, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
246, 5l91A, 0.8700, 2.54, 0.294, 391, 378, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
247, 3wrmA, 0.8700, 2.38, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450CAM
248, 3p6nA, 0.8700, 2.40, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
249, 3ol5A, 0.8700, 2.40, 0.220, 405, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
250, 2zuiA, 0.8700, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
251, 2qbmA, 0.8700, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
252, 1t86B, 0.8700, 2.36, 0.218, 406, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
253, 5wk9A, 0.8699, 2.41, 0.220, 405, 382, R186AP450CAM WITH CN AND CAMPHOR
254, 5h1zA, 0.8699, 2.76, 0.250, 400, 388, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
255, 3wrlE, 0.8699, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF P450CAM
256, 2yooB, 0.8699, 2.42, 0.297, 395, 381, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
257, 2frzA, 0.8699, 2.38, 0.220, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
258, 2a1mB, 0.8699, 2.38, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
259, 1t87B, 0.8699, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
260, 1o76A, 0.8699, 2.37, 0.218, 404, 381, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
261, 4l4dA, 0.8698, 2.37, 0.218, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
262, 3wrmF, 0.8698, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450CAM
263, 2zwtA, 0.8698, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
264, 2a1mA, 0.8698, 2.37, 0.218, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
265, 5nwsA, 0.8697, 2.43, 0.394, 395, 381, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
266, 5kt1A, 0.8697, 2.52, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
267, 4kkyX, 0.8697, 2.37, 0.218, 411, 381, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
268, 2d09A, 0.8697, 2.77, 0.336, 404, 390, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
269, 2a1oB, 0.8697, 2.38, 0.220, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
270, 2yooC, 0.8696, 2.36, 0.295, 395, 380, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
271, 5u6uA, 0.8695, 2.52, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
272, 2zawA, 0.8695, 2.37, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
273, 2a1nB, 0.8695, 2.38, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
274, 6cp4A, 0.8694, 2.38, 0.218, 405, 381, P450CAM D251N MUTANT
275, 2gqxB, 0.8694, 2.38, 0.226, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
276, 1j51D, 0.8694, 2.38, 0.226, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
277, 1dz6B, 0.8694, 2.37, 0.218, 405, 381, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
278, 5mnvB, 0.8693, 2.70, 0.361, 394, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
279, 5mnsE, 0.8693, 2.75, 0.360, 395, 389, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
280, 3wrhE, 0.8693, 2.38, 0.223, 405, 381, CRYSTAL STRUCTURE OF P450CAM
281, 1t93A, 0.8693, 2.77, 0.333, 403, 390, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
282, 5u6wA, 0.8692, 2.53, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
283, 1yrcA, 0.8692, 2.39, 0.223, 405, 381, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
284, 5wk7A, 0.8691, 2.43, 0.220, 405, 382, P450CAM MUTANT R186A
285, 5l1pA, 0.8691, 2.76, 0.345, 397, 388, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
286, 4ek1A, 0.8691, 2.39, 0.218, 403, 381, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
287, 3fwjA, 0.8691, 2.39, 0.220, 405, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
288, 2wivA, 0.8691, 2.34, 0.263, 391, 380, CYTOCHROME-P450 XPLA HEME DOMAIN P21
289, 2qblA, 0.8691, 2.39, 0.223, 405, 381, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
290, 1j51B, 0.8691, 2.39, 0.226, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
291, 1c8jB, 0.8691, 2.39, 0.223, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
292, 5kdyA, 0.8690, 2.54, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
293, 3fwgA, 0.8690, 2.39, 0.223, 404, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
294, 3ejeB, 0.8689, 2.14, 0.349, 378, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
295, 3ejbF, 0.8689, 2.18, 0.340, 378, 373, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
296, 2fe6A, 0.8689, 2.39, 0.220, 405, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
297, 1mpwB, 0.8689, 2.39, 0.226, 405, 381, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
298, 5d40A, 0.8688, 2.70, 0.265, 403, 388, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
299, 4c9oA, 0.8688, 2.45, 0.214, 408, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
300, 4c9nA, 0.8688, 2.45, 0.214, 408, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
301, 2qbnA, 0.8688, 2.39, 0.218, 405, 381, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
302, 1t88B, 0.8688, 2.40, 0.223, 405, 381, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
303, 4g3rA, 0.8687, 2.38, 0.218, 407, 381, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
304, 4ep6A, 0.8687, 2.34, 0.268, 392, 380, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
305, 4c9pA, 0.8687, 2.45, 0.217, 408, 383, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
306, 4c9kA, 0.8687, 2.45, 0.214, 408, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
307, 2wivB, 0.8687, 2.35, 0.263, 391, 380, CYTOCHROME-P450 XPLA HEME DOMAIN P21
308, 1dz6A, 0.8687, 2.39, 0.218, 404, 381, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
309, 4c9oB, 0.8686, 2.46, 0.214, 407, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
310, 4c9lA, 0.8686, 2.45, 0.214, 408, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
311, 2frzB, 0.8686, 2.39, 0.226, 405, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
312, 4c9pB, 0.8685, 2.46, 0.217, 407, 383, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
313, 4c9lB, 0.8685, 2.46, 0.214, 407, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
314, 4c9kB, 0.8685, 2.46, 0.214, 407, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
315, 3fwfB, 0.8685, 2.40, 0.220, 405, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
316, 4oqrA, 0.8684, 2.31, 0.365, 386, 378, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
317, 4l4cB, 0.8684, 2.40, 0.226, 405, 381, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
318, 4c9mB, 0.8684, 2.46, 0.214, 407, 383, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
319, 3lxhA, 0.8684, 2.46, 0.214, 408, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
320, 2qboA, 0.8684, 2.39, 0.218, 405, 381, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
321, 2jjpA, 0.8684, 2.55, 0.329, 397, 380, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
322, 2h7sA, 0.8684, 2.39, 0.215, 405, 381, L244A MUTANT OF CYTOCHROME P450CAM
323, 2feuA, 0.8684, 2.40, 0.223, 404, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
324, 1dz4A, 0.8684, 2.40, 0.218, 404, 381, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
325, 5d3uA, 0.8683, 2.71, 0.265, 403, 388, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
326, 3fwiA, 0.8683, 2.40, 0.220, 405, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
327, 4c9mA, 0.8682, 2.46, 0.214, 408, 383, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
328, 5l1qA, 0.8681, 2.77, 0.345, 397, 388, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
329, 3tktA, 0.8680, 2.68, 0.251, 411, 387, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
330, 3l63A, 0.8680, 2.41, 0.218, 405, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
331, 4pwvA, 0.8679, 2.66, 0.258, 404, 383, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
332, 4dnzC, 0.8679, 2.58, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
333, 2wiyA, 0.8679, 2.35, 0.266, 394, 380, CYTOCHROME P450 XPLA HEME DOMAIN P21212
334, 2h7sC, 0.8679, 2.40, 0.215, 405, 381, L244A MUTANT OF CYTOCHROME P450CAM
335, 5kdzA, 0.8678, 2.56, 0.285, 393, 383, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
336, 3lxiA, 0.8678, 2.47, 0.214, 408, 383, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
337, 2jjnA, 0.8678, 2.42, 0.328, 395, 378, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
338, 5l1uA, 0.8677, 2.78, 0.348, 397, 388, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
339, 4l4gA, 0.8677, 2.42, 0.220, 405, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
340, 5l91B, 0.8676, 2.50, 0.294, 389, 377, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
341, 4c9nB, 0.8675, 2.48, 0.214, 407, 383, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
342, 2m56A, 0.8675, 2.42, 0.223, 404, 381, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
343, 5uvbA, 0.8674, 2.57, 0.282, 393, 383, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
344, 4egmC, 0.8674, 2.58, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
345, 5mnsA, 0.8672, 2.70, 0.358, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
346, 5l1vA, 0.8672, 2.78, 0.345, 397, 388, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
347, 5l1sA, 0.8671, 2.79, 0.345, 397, 388, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
348, 4egnC, 0.8671, 2.60, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
349, 3lxhB, 0.8671, 2.49, 0.214, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
350, 4g3rB, 0.8670, 2.42, 0.223, 405, 381, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
351, 3lxiB, 0.8670, 2.49, 0.214, 407, 383, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
352, 4do1C, 0.8669, 2.59, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
353, 3fwfA, 0.8668, 2.43, 0.220, 404, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
354, 5mnsB, 0.8667, 2.70, 0.358, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
355, 5d3uB, 0.8667, 2.73, 0.265, 403, 388, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
356, 5d40B, 0.8666, 2.73, 0.265, 403, 388, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
357, 4egoC, 0.8666, 2.61, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
358, 1t85A, 0.8665, 2.44, 0.218, 406, 381, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
359, 5l1rA, 0.8664, 2.79, 0.345, 397, 388, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
360, 5l1tA, 0.8663, 2.80, 0.345, 397, 388, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
361, 5l1oA, 0.8663, 2.80, 0.345, 397, 388, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
362, 4dnjA, 0.8662, 2.62, 0.279, 399, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
363, 2z36A, 0.8659, 2.75, 0.352, 403, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
364, 2fr7A, 0.8658, 2.44, 0.286, 397, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
365, 4do1D, 0.8656, 2.61, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
366, 2jjoA, 0.8656, 2.51, 0.326, 393, 377, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
367, 5mnsD, 0.8655, 2.80, 0.360, 395, 389, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
368, 5l1wA, 0.8654, 2.78, 0.349, 396, 387, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
369, 2x5lA, 0.8654, 2.76, 0.262, 414, 386, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
370, 3g5fA, 0.8653, 2.81, 0.248, 394, 387, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
371, 5mnsC, 0.8652, 2.74, 0.358, 395, 388, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
372, 4egnD, 0.8651, 2.62, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
373, 5ibeA, 0.8650, 2.81, 0.248, 394, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
374, 4ipsA, 0.8649, 2.82, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
375, 3cxzA, 0.8649, 2.82, 0.251, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
376, 2d0eA, 0.8649, 2.85, 0.338, 404, 390, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
377, 1n40A, 0.8649, 2.82, 0.248, 394, 387, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
378, 5edtA, 0.8647, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
379, 4egoD, 0.8647, 2.63, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
380, 3g5hA, 0.8647, 2.82, 0.248, 394, 387, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
381, 3cxyA, 0.8647, 2.82, 0.248, 393, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
382, 3cxxA, 0.8647, 2.81, 0.245, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
383, 2h7rA, 0.8647, 2.47, 0.218, 405, 381, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
384, 2z36B, 0.8646, 2.78, 0.351, 404, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
385, 3cxvA, 0.8645, 2.82, 0.245, 394, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
386, 5ibdA, 0.8644, 2.82, 0.245, 394, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
387, 4tpoA, 0.8644, 2.61, 0.271, 398, 384, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
388, 3cy0A, 0.8643, 2.82, 0.251, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
389, 5o4kA, 0.8642, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
390, 4ipwA, 0.8642, 2.83, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
391, 4g46A, 0.8642, 2.83, 0.248, 394, 387, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
392, 3cy1A, 0.8641, 2.82, 0.248, 394, 387, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
393, 5wp2A, 0.8640, 2.82, 0.248, 394, 387, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
394, 5op9A, 0.8640, 2.83, 0.248, 394, 387, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
395, 5fyfB, 0.8640, 2.39, 0.231, 411, 377, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
396, 4g2gA, 0.8640, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
397, 4g1xA, 0.8640, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
398, 3zbyC, 0.8640, 2.65, 0.283, 402, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
399, 3zbyB, 0.8640, 2.65, 0.283, 404, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
400, 3zbyA, 0.8640, 2.65, 0.283, 402, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
401, 5ibjA, 0.8639, 2.83, 0.248, 393, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
402, 4ktjA, 0.8639, 2.83, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
403, 4g48A, 0.8639, 2.84, 0.245, 394, 387, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
404, 4g47A, 0.8639, 2.83, 0.248, 394, 387, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
405, 4g44A, 0.8639, 2.83, 0.248, 394, 387, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
406, 2ij7E, 0.8639, 2.68, 0.249, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
407, 5ibhA, 0.8638, 2.83, 0.248, 393, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
408, 4iq9A, 0.8638, 2.83, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
409, 4iq7A, 0.8638, 2.83, 0.248, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
410, 4egmD, 0.8638, 2.64, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
411, 3zbyF, 0.8638, 2.65, 0.283, 402, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
412, 3zbyD, 0.8638, 2.64, 0.283, 402, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
413, 1cptA, 0.8638, 2.76, 0.220, 412, 386, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
414, 4g45A, 0.8637, 2.83, 0.248, 394, 387, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
415, 4egpB, 0.8637, 2.46, 0.291, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
416, 3zbyE, 0.8637, 2.66, 0.283, 402, 381, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
417, 2ij5B, 0.8637, 2.71, 0.244, 390, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
418, 4uaxA, 0.8636, 2.71, 0.283, 401, 381, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
419, 4jx1F, 0.8636, 2.59, 0.217, 405, 382, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
420, 4dnzD, 0.8636, 2.64, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
421, 4ktkA, 0.8634, 2.84, 0.248, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
422, 4ictA, 0.8634, 2.84, 0.245, 394, 387, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
423, 5ibiA, 0.8633, 2.84, 0.248, 393, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
424, 5ibfA, 0.8633, 2.84, 0.248, 393, 387, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
425, 4ktlA, 0.8633, 2.84, 0.245, 394, 387, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
426, 4apyA, 0.8633, 3.01, 0.274, 414, 390, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
427, 5opaA, 0.8632, 2.84, 0.248, 393, 387, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
428, 4egoA, 0.8632, 2.66, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
429, 4egmB, 0.8632, 2.66, 0.287, 394, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
430, 4do1B, 0.8632, 2.66, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
431, 5dqnA, 0.8631, 2.99, 0.280, 410, 389, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
432, 4wq0A, 0.8631, 2.60, 0.333, 397, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
433, 4egnA, 0.8631, 2.66, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
434, 4dnzA, 0.8631, 2.66, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
435, 3r9bC, 0.8631, 2.67, 0.330, 391, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
436, 3r9bB, 0.8630, 2.67, 0.330, 391, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
437, 3r9bA, 0.8629, 2.67, 0.330, 391, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
438, 4egoB, 0.8628, 2.67, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
439, 5l90A, 0.8627, 2.43, 0.297, 385, 374, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
440, 4dnzB, 0.8625, 2.67, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF CYP199A4
441, 4egmA, 0.8624, 2.67, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
442, 4do1A, 0.8624, 2.67, 0.287, 393, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
443, 4l36A, 0.8623, 2.65, 0.271, 396, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
444, 4egnB, 0.8623, 2.67, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
445, 5o4lA, 0.8621, 2.82, 0.249, 393, 386, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
446, 3p6tA, 0.8620, 2.48, 0.211, 404, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
447, 2ij5A, 0.8617, 2.86, 0.246, 392, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
448, 2xc3A, 0.8616, 2.74, 0.260, 409, 384, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
449, 4egpA, 0.8615, 2.69, 0.287, 393, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
450, 3iw0A, 0.8615, 2.89, 0.265, 407, 388, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
451, 4ktfA, 0.8614, 2.82, 0.249, 392, 386, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
452, 3nv6A, 0.8614, 2.57, 0.207, 404, 382, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
453, 1n4gA, 0.8613, 2.78, 0.242, 392, 385, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
454, 4jx1E, 0.8612, 2.60, 0.219, 405, 383, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
455, 1rf9A, 0.8612, 2.65, 0.220, 404, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
456, 5l90B, 0.8610, 2.48, 0.297, 385, 374, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
457, 2ij5C, 0.8608, 2.86, 0.233, 394, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
458, 4jx1B, 0.8606, 2.50, 0.214, 405, 379, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
459, 4jx1A, 0.8604, 2.60, 0.223, 405, 382, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
460, 2ij7B, 0.8604, 2.79, 0.247, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
461, 2l8mA, 0.8602, 2.53, 0.215, 405, 382, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
462, 1qmqA, 0.8600, 2.52, 0.214, 406, 379, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
463, 5mnsF, 0.8599, 2.74, 0.355, 393, 386, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
464, 4jwuA, 0.8599, 2.48, 0.216, 405, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
465, 2xn8A, 0.8598, 2.76, 0.260, 409, 384, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
466, 3zkpA, 0.8597, 2.53, 0.328, 390, 375, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
467, 3ivyA, 0.8595, 2.64, 0.258, 399, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
468, 2ij7D, 0.8592, 2.83, 0.247, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
469, 1k2oB, 0.8592, 2.49, 0.211, 406, 379, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
470, 4dxyA, 0.8591, 2.63, 0.209, 406, 383, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
471, 5it1D, 0.8590, 2.96, 0.373, 395, 386, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
472, 5it1A, 0.8590, 2.96, 0.373, 395, 386, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
473, 2ij5D, 0.8590, 2.83, 0.247, 391, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
474, 5it1C, 0.8586, 2.97, 0.373, 395, 386, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
475, 5it1B, 0.8586, 2.97, 0.370, 395, 386, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
476, 4jwuB, 0.8586, 2.56, 0.218, 403, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
477, 3p6sA, 0.8586, 2.44, 0.212, 404, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
478, 3e5lA, 0.8583, 2.91, 0.365, 394, 386, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
479, 2ij7A, 0.8581, 2.88, 0.247, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
480, 5gxgA, 0.8580, 2.50, 0.217, 401, 378, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
481, 2xbkA, 0.8580, 2.70, 0.318, 391, 381, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
482, 1k2oA, 0.8580, 2.53, 0.214, 406, 379, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
483, 5ofqD, 0.8579, 2.49, 0.328, 387, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
484, 3iw2A, 0.8578, 2.71, 0.258, 398, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
485, 5vwsA, 0.8576, 1.89, 0.344, 376, 366, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
486, 5ibgA, 0.8576, 2.81, 0.247, 390, 384, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
487, 2ij7C, 0.8576, 2.84, 0.234, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
488, 4l0fA, 0.8575, 2.85, 0.242, 437, 384, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
489, 3iw1A, 0.8574, 2.64, 0.256, 398, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
490, 3p6uA, 0.8573, 2.41, 0.215, 402, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
491, 1ulwA, 0.8573, 3.07, 0.297, 399, 390, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
492, 5ofqC, 0.8572, 2.51, 0.328, 386, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
493, 5hdiA, 0.8572, 2.92, 0.282, 397, 383, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
494, 1gedA, 0.8572, 2.90, 0.301, 399, 385, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
495, 3w9cA, 0.8571, 2.52, 0.217, 401, 378, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
496, 5ofqA, 0.8569, 2.53, 0.323, 386, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
497, 5omrA, 0.8568, 2.54, 0.218, 403, 381, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
498, 2ij7F, 0.8568, 2.88, 0.247, 391, 385, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
499, 5ofqB, 0.8561, 2.54, 0.323, 386, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
500, 2ygxD, 0.8559, 2.68, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
501, 5omsA, 0.8558, 2.55, 0.218, 403, 381, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
502, 5y5mA, 0.8556, 3.01, 0.299, 399, 388, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
503, 5y5jA, 0.8555, 3.01, 0.299, 399, 388, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
504, 5y5iA, 0.8555, 3.01, 0.299, 399, 388, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
505, 2ygxB, 0.8555, 2.68, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
506, 5y5lA, 0.8554, 3.01, 0.299, 399, 388, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
507, 5y5kA, 0.8554, 3.01, 0.299, 399, 388, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
508, 2ij5E, 0.8554, 2.69, 0.249, 387, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
509, 2ygxA, 0.8550, 2.69, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
510, 1romA, 0.8547, 2.96, 0.301, 399, 386, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
511, 5y5lB, 0.8546, 2.95, 0.301, 399, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
512, 5y5kB, 0.8545, 2.95, 0.301, 399, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
513, 5y5jB, 0.8545, 2.96, 0.301, 399, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
514, 3zsnC, 0.8545, 2.72, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
515, 3zsnB, 0.8545, 2.72, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
516, 3p6qA, 0.8545, 2.59, 0.220, 401, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
517, 5y5mB, 0.8544, 2.96, 0.301, 399, 385, SFX STRUCTURE OF CYTOCHROME P450NOR: A COMPLETE DARK DATA WITHOUT PUMP LASER (RESTING STATE) 
518, 5y5iB, 0.8543, 2.96, 0.301, 399, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
519, 5omuA, 0.8543, 2.53, 0.218, 402, 380, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
520, 3zsnA, 0.8543, 2.72, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
521, 2ygxC, 0.8542, 2.71, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
522, 2romA, 0.8541, 2.78, 0.285, 399, 382, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
523, 2ycaA, 0.8540, 2.71, 0.373, 393, 381, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
524, 3rwlA, 0.8537, 2.97, 0.229, 404, 385, STRUCTURE OF P450PYR HYDROXYLASE
525, 2y5zC, 0.8537, 2.76, 0.374, 394, 382, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
526, 5y1iB, 0.8536, 2.76, 0.337, 394, 380, THE CRYSTAL STRUCTURE OF GFSF
527, 2y5nA, 0.8536, 2.78, 0.374, 394, 382, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
528, 2y5zB, 0.8535, 2.76, 0.374, 394, 382, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
529, 2ij5F, 0.8535, 2.63, 0.240, 384, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
530, 2y5nB, 0.8534, 2.74, 0.377, 400, 382, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
531, 5y5hA, 0.8533, 3.00, 0.301, 400, 386, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
532, 1cl6A, 0.8533, 2.93, 0.304, 399, 385, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
533, 3nv5A, 0.8532, 2.47, 0.212, 399, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
534, 2y46C, 0.8531, 2.74, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
535, 2y46B, 0.8530, 2.74, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
536, 1f26A, 0.8530, 2.93, 0.304, 399, 385, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
537, 2y98A, 0.8529, 2.74, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
538, 4l36B, 0.8528, 2.62, 0.277, 392, 379, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
539, 2y46A, 0.8528, 2.74, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
540, 1f24A, 0.8527, 3.05, 0.302, 399, 388, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
541, 1jfbA, 0.8526, 2.97, 0.301, 399, 386, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
542, 3wriB, 0.8524, 2.44, 0.211, 403, 375, CRYSTAL STRUCTURE OF P450CAM
543, 5y5gA, 0.8523, 3.02, 0.301, 400, 386, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
544, 3wriA, 0.8522, 2.44, 0.211, 403, 375, CRYSTAL STRUCTURE OF P450CAM
545, 3p6wA, 0.8522, 2.42, 0.217, 400, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
546, 2y5zA, 0.8521, 2.74, 0.373, 393, 381, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
547, 1cmjA, 0.8521, 2.95, 0.304, 399, 385, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
548, 5hdiB, 0.8519, 2.84, 0.282, 393, 379, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
549, 1eheA, 0.8519, 3.10, 0.298, 399, 389, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
550, 3l62A, 0.8518, 2.43, 0.211, 400, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
551, 1ehfA, 0.8518, 2.95, 0.304, 399, 385, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
552, 1jfcA, 0.8517, 2.95, 0.304, 399, 385, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
553, 1gejA, 0.8514, 3.11, 0.298, 399, 389, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
554, 1geiA, 0.8514, 3.11, 0.298, 399, 389, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
555, 1f25A, 0.8514, 3.11, 0.298, 399, 389, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
556, 5y5fA, 0.8513, 3.00, 0.301, 399, 385, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
557, 1ehgA, 0.8510, 2.96, 0.304, 399, 385, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
558, 1cmnA, 0.8510, 2.96, 0.304, 399, 385, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
559, 4z5pA, 0.8508, 2.65, 0.400, 388, 380, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
560, 4aw3B, 0.8507, 2.76, 0.373, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
561, 4aw3A, 0.8507, 2.75, 0.375, 393, 381, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
562, 4tpnA, 0.8501, 2.55, 0.271, 386, 376, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
563, 3p6xA, 0.8499, 2.42, 0.214, 399, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
564, 4l0eA, 0.8495, 2.99, 0.234, 440, 384, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
565, 3ofuC, 0.8493, 2.54, 0.243, 396, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
566, 3p6rA, 0.8490, 2.55, 0.221, 398, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
567, 3p6vA, 0.8489, 2.40, 0.218, 398, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
568, 4z5pB, 0.8487, 2.84, 0.413, 388, 383, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
569, 3oftA, 0.8487, 2.56, 0.241, 396, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
570, 3ofuA, 0.8485, 2.58, 0.232, 396, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
571, 2uuqA, 0.8484, 2.84, 0.281, 394, 377, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
572, 3ofuB, 0.8482, 2.60, 0.232, 396, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
573, 3p3zA, 0.8481, 2.95, 0.332, 407, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
574, 3nc6B, 0.8480, 2.30, 0.265, 389, 370, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
575, 5lieB, 0.8478, 2.91, 0.326, 397, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
576, 2lqdA, 0.8478, 2.75, 0.220, 405, 381, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
577, 4wpzA, 0.8477, 2.41, 0.336, 386, 372, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
578, 3tywC, 0.8476, 2.87, 0.346, 398, 381, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
579, 2whfA, 0.8473, 2.88, 0.279, 394, 377, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
580, 4xe3B, 0.8471, 2.88, 0.340, 394, 382, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
581, 3tywD, 0.8470, 2.88, 0.346, 399, 381, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
582, 3ofuD, 0.8468, 2.51, 0.242, 394, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
583, 1s1fA, 0.8466, 2.95, 0.325, 397, 385, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
584, 5y1iA, 0.8460, 2.78, 0.332, 388, 376, THE CRYSTAL STRUCTURE OF GFSF
585, 4fb2A, 0.8459, 2.61, 0.243, 392, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
586, 6c93A, 0.8458, 2.84, 0.172, 478, 384, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
587, 2dkkA, 0.8453, 3.12, 0.328, 399, 387, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
588, 6c94A, 0.8450, 2.86, 0.169, 482, 384, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
589, 3p3oA, 0.8448, 3.02, 0.332, 416, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
590, 2wgyA, 0.8448, 2.88, 0.277, 394, 376, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
591, 4fb2B, 0.8447, 2.63, 0.240, 392, 375, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
592, 3oftB, 0.8447, 2.50, 0.245, 393, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
593, 3abbA, 0.8446, 2.43, 0.348, 383, 371, CRYSTAL STRUCTURE OF CYP105D6
594, 5lieA, 0.8445, 2.47, 0.342, 379, 371, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
595, 6f8aB, 0.8436, 2.84, 0.260, 394, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
596, 5t6qA, 0.8431, 2.90, 0.167, 472, 384, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
597, 4ggvA, 0.8430, 2.81, 0.370, 396, 376, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
598, 5ikiB, 0.8427, 3.06, 0.285, 399, 386, CYP106A2 WITH SUBSTRATE ABIETIC ACID
599, 3tywA, 0.8427, 3.01, 0.346, 397, 381, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
600, 3tywB, 0.8425, 2.99, 0.346, 397, 381, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
601, 2z3tA, 0.8425, 2.79, 0.338, 385, 376, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
602, 5ncbA, 0.8423, 2.65, 0.223, 396, 376, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
603, 3l61A, 0.8422, 2.46, 0.216, 396, 371, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
604, 4fb2D, 0.8421, 2.64, 0.241, 391, 374, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
605, 6f8cA, 0.8419, 2.87, 0.260, 394, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
606, 5li8A, 0.8415, 2.80, 0.345, 390, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
607, 4xe3A, 0.8415, 2.98, 0.340, 394, 382, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
608, 6f88A, 0.8411, 2.88, 0.260, 394, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
609, 3p3xA, 0.8411, 2.90, 0.329, 397, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
610, 5mnvA, 0.8408, 2.97, 0.350, 397, 383, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
611, 3ld6A, 0.8406, 2.97, 0.161, 445, 385, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
612, 5mnvH, 0.8405, 2.98, 0.347, 395, 383, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
613, 3ld6B, 0.8405, 3.00, 0.158, 444, 385, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
614, 2nz5A, 0.8404, 3.03, 0.323, 399, 384, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
615, 3jusA, 0.8402, 2.98, 0.161, 445, 385, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
616, 4fb2C, 0.8400, 2.62, 0.241, 390, 373, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
617, 5mnvD, 0.8399, 2.99, 0.346, 394, 382, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
618, 4oqsA, 0.8396, 2.77, 0.365, 384, 373, CRYSTAL STRUCTURE OF CYP105AS1
619, 3p3xB, 0.8396, 2.92, 0.329, 399, 383, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
620, 3nc7B, 0.8396, 2.31, 0.273, 384, 366, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
621, 2wh8A, 0.8396, 2.90, 0.278, 392, 374, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
622, 2z3tC, 0.8394, 2.85, 0.339, 383, 375, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
623, 4uhiC, 0.8392, 3.02, 0.158, 442, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
624, 3jusB, 0.8391, 3.00, 0.161, 445, 385, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
625, 4uhlF, 0.8390, 3.02, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
626, 4uhlB, 0.8390, 3.00, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
627, 3oftC, 0.8389, 2.51, 0.241, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
628, 2wh8D, 0.8389, 2.97, 0.275, 389, 375, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
629, 5de9B, 0.8388, 2.99, 0.312, 402, 382, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
630, 4uhlE, 0.8386, 3.03, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
631, 3tzoB, 0.8385, 2.98, 0.312, 402, 382, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
632, 3nc3B, 0.8385, 2.44, 0.266, 385, 368, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
633, 5de9A, 0.8380, 3.01, 0.312, 402, 382, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
634, 3ofuF, 0.8380, 2.55, 0.247, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
635, 4uhlC, 0.8379, 3.03, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
636, 3ofuE, 0.8379, 2.54, 0.244, 390, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
637, 3tzoA, 0.8378, 3.02, 0.312, 402, 382, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
638, 3e5kA, 0.8378, 2.73, 0.374, 382, 374, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
639, 5livC, 0.8377, 2.92, 0.260, 395, 381, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
640, 5li6B, 0.8377, 2.46, 0.342, 376, 368, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
641, 6cr2B, 0.8376, 3.04, 0.155, 469, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
642, 4uhlA, 0.8376, 3.04, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
643, 2wh8B, 0.8375, 2.96, 0.273, 392, 374, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
644, 6f85B, 0.8374, 2.87, 0.261, 392, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
645, 4uhiD, 0.8374, 3.06, 0.158, 442, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
646, 5li6A, 0.8373, 2.52, 0.344, 377, 369, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
647, 1uedA, 0.8373, 2.44, 0.289, 391, 367, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
648, 5ik1A, 0.8371, 2.56, 0.224, 394, 370, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
649, 4uymA, 0.8370, 3.07, 0.160, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
650, 3p3lA, 0.8370, 3.04, 0.326, 403, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
651, 2nz5B, 0.8370, 3.20, 0.332, 399, 386, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
652, 4uhiA, 0.8369, 3.05, 0.158, 442, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
653, 2wh8C, 0.8367, 2.99, 0.278, 388, 374, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
654, 5vbuC, 0.8364, 2.94, 0.188, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
655, 4uhlG, 0.8364, 3.05, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
656, 5vbuB, 0.8363, 2.96, 0.188, 441, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
657, 4uhlH, 0.8363, 3.08, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
658, 3p3lB, 0.8363, 3.05, 0.323, 403, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
659, 2nzaA, 0.8362, 3.13, 0.326, 397, 384, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
660, 6cr2A, 0.8361, 3.06, 0.158, 469, 386, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
661, 5mnvF, 0.8361, 3.09, 0.347, 395, 383, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
662, 5frbA, 0.8361, 3.10, 0.160, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
663, 4y8wA, 0.8361, 2.89, 0.186, 440, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
664, 2uwhF, 0.8361, 3.07, 0.145, 458, 385, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
665, 2z3tD, 0.8358, 2.64, 0.340, 379, 371, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
666, 4y8wB, 0.8357, 2.97, 0.185, 440, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
667, 5vbuA, 0.8356, 2.96, 0.185, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
668, 5l92B, 0.8355, 2.43, 0.298, 370, 363, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
669, 1uedB, 0.8354, 2.50, 0.285, 391, 368, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
670, 5kyoB, 0.8353, 2.74, 0.197, 393, 376, CRYSTAL STRUCTURE OF CYP101J2
671, 2ve3B, 0.8353, 2.91, 0.207, 427, 381, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
672, 2ij4A, 0.8353, 3.11, 0.153, 451, 385, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
673, 6f8cB, 0.8352, 2.93, 0.261, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
674, 4uhlD, 0.8352, 3.09, 0.158, 445, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
675, 3dl9B, 0.8352, 3.08, 0.159, 467, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
676, 4y8wC, 0.8351, 2.96, 0.188, 442, 383, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
677, 3c6gB, 0.8351, 3.07, 0.159, 467, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
678, 4uhiB, 0.8350, 3.07, 0.158, 442, 386, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
679, 3czhB, 0.8348, 3.08, 0.159, 467, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
680, 4uylA, 0.8347, 3.09, 0.158, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
681, 4uymB, 0.8346, 3.09, 0.158, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
682, 3nc5A, 0.8346, 2.35, 0.269, 384, 364, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
683, 2ve3A, 0.8344, 2.99, 0.210, 435, 381, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
684, 1se6B, 0.8341, 3.09, 0.314, 402, 382, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
685, 6f85A, 0.8340, 2.95, 0.264, 392, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
686, 4uylB, 0.8340, 3.10, 0.158, 470, 387, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
687, 5livA, 0.8338, 2.93, 0.258, 397, 380, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
688, 6f8aA, 0.8336, 2.95, 0.258, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
689, 3gw9C, 0.8333, 3.01, 0.167, 449, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
690, 5kyoA, 0.8332, 2.74, 0.195, 394, 375, CRYSTAL STRUCTURE OF CYP101J2
691, 5jqvA, 0.8331, 3.03, 0.138, 453, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
692, 1zoaA, 0.8331, 3.09, 0.148, 457, 384, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
693, 5jqvB, 0.8329, 3.13, 0.138, 453, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
694, 5hiwA, 0.8329, 3.04, 0.227, 391, 379, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
695, 4kewA, 0.8329, 3.11, 0.159, 450, 384, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
696, 5mnvE, 0.8328, 2.91, 0.347, 390, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
697, 5kyoE, 0.8328, 2.79, 0.205, 390, 376, CRYSTAL STRUCTURE OF CYP101J2
698, 2uwhE, 0.8328, 3.13, 0.145, 458, 385, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
699, 4rm4A, 0.8327, 1.94, 0.321, 364, 355, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
700, 3czhA, 0.8327, 3.10, 0.156, 465, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
701, 4zfaA, 0.8325, 3.13, 0.145, 460, 385, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
702, 4g3jA, 0.8325, 3.02, 0.167, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
703, 5xhjB, 0.8324, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
704, 3ekbB, 0.8324, 3.08, 0.141, 457, 384, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
705, 1zoaB, 0.8324, 3.10, 0.148, 457, 384, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
706, 1smjA, 0.8324, 3.08, 0.146, 455, 384, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
707, 5jquB, 0.8323, 3.06, 0.138, 453, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
708, 5jq2A, 0.8323, 3.07, 0.146, 457, 383, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
709, 5dyzA, 0.8322, 3.13, 0.145, 445, 385, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
710, 3qz1A, 0.8322, 3.03, 0.156, 445, 384, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
711, 3dl9A, 0.8321, 3.11, 0.156, 465, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
712, 1smjD, 0.8321, 3.07, 0.146, 454, 384, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
713, 1fagA, 0.8321, 3.09, 0.148, 455, 384, STRUCTURE OF CYTOCHROME P450
714, 4h24C, 0.8320, 3.10, 0.151, 456, 384, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
715, 2wuzA, 0.8320, 3.12, 0.172, 444, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
716, 5b2wB, 0.8319, 3.09, 0.148, 452, 384, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
717, 1zo9A, 0.8318, 3.11, 0.148, 458, 384, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
718, 1jpzA, 0.8318, 3.10, 0.151, 456, 384, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
719, 3ekbA, 0.8317, 3.13, 0.146, 442, 383, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
720, 3c6gA, 0.8317, 3.12, 0.156, 464, 384, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
721, 1fagC, 0.8317, 3.10, 0.148, 455, 384, STRUCTURE OF CYTOCHROME P450
722, 5dypA, 0.8316, 3.17, 0.151, 440, 385, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
723, 3mgxB, 0.8316, 2.93, 0.283, 391, 375, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
724, 3kx3A, 0.8316, 3.11, 0.151, 454, 384, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
725, 1smiB, 0.8316, 3.10, 0.151, 455, 384, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
726, 3kx3B, 0.8315, 3.11, 0.148, 456, 384, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
727, 1fagB, 0.8315, 3.10, 0.148, 455, 384, STRUCTURE OF CYTOCHROME P450
728, 6f88B, 0.8314, 2.98, 0.264, 393, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
729, 5jqvD, 0.8314, 3.08, 0.141, 454, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
730, 1smjB, 0.8314, 3.05, 0.144, 455, 383, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
731, 1fagD, 0.8314, 3.10, 0.148, 455, 384, STRUCTURE OF CYTOCHROME P450
732, 5xhjA, 0.8313, 3.11, 0.146, 453, 384, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
733, 5og9B, 0.8313, 3.13, 0.143, 454, 385, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
734, 1jpzB, 0.8313, 3.11, 0.148, 458, 384, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
735, 2ij4B, 0.8312, 3.09, 0.148, 455, 384, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
736, 5jquD, 0.8310, 3.05, 0.133, 454, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
737, 3k1oA, 0.8310, 3.14, 0.172, 442, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
738, 3nplA, 0.8309, 3.09, 0.148, 456, 384, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
739, 2uwhC, 0.8309, 3.16, 0.145, 458, 385, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
740, 1zo9B, 0.8308, 3.12, 0.148, 458, 384, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
741, 5yswA, 0.8307, 2.50, 0.380, 374, 366, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
742, 5xa3D, 0.8307, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
743, 3kx5B, 0.8307, 3.12, 0.146, 455, 384, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
744, 1smjC, 0.8307, 3.07, 0.144, 455, 383, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
745, 5xa3A, 0.8306, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
746, 5jquC, 0.8306, 3.07, 0.138, 453, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
747, 5b2uB, 0.8306, 3.06, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
748, 4keyA, 0.8304, 3.15, 0.159, 450, 384, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
749, 5jquA, 0.8303, 3.03, 0.139, 452, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
750, 5b2wA, 0.8303, 3.11, 0.146, 452, 384, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
751, 3e5jA, 0.8303, 3.05, 0.375, 390, 379, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
752, 2uwhD, 0.8303, 3.12, 0.148, 458, 384, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
753, 4o4pB, 0.8302, 3.14, 0.159, 446, 384, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
754, 3pm0A, 0.8302, 2.81, 0.168, 459, 376, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
755, 3kx4B, 0.8302, 3.12, 0.146, 454, 384, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
756, 4wg2A, 0.8301, 3.09, 0.156, 461, 384, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
757, 2uwhA, 0.8301, 3.12, 0.148, 458, 384, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
758, 3cbdA, 0.8300, 3.17, 0.151, 455, 385, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
759, 5eacA, 0.8299, 3.15, 0.150, 530, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
760, 3nc7A, 0.8299, 2.43, 0.268, 379, 362, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
761, 5jqvC, 0.8298, 3.13, 0.151, 452, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
762, 4wg2C, 0.8298, 3.10, 0.154, 460, 384, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
763, 4lxjA, 0.8298, 3.15, 0.150, 530, 386, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
764, 2z3tB, 0.8298, 2.54, 0.341, 376, 367, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
765, 4g7gB, 0.8297, 3.06, 0.164, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
766, 3cbdB, 0.8297, 3.13, 0.154, 455, 384, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
767, 5jtdA, 0.8296, 3.07, 0.144, 458, 383, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
768, 5dyzC, 0.8296, 3.17, 0.145, 453, 385, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
769, 4fxbA, 0.8296, 3.01, 0.343, 390, 376, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
770, 4dufC, 0.8296, 3.07, 0.146, 456, 383, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
771, 2wuzB, 0.8296, 3.19, 0.172, 444, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
772, 5kyoC, 0.8295, 2.72, 0.196, 390, 373, CRYSTAL STRUCTURE OF CYP101J2
773, 4dufD, 0.8295, 3.13, 0.148, 456, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
774, 2uwhB, 0.8295, 3.13, 0.148, 458, 384, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
775, 5xa3C, 0.8293, 3.07, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
776, 5xa3B, 0.8293, 3.07, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
777, 4kpaA, 0.8293, 3.21, 0.156, 461, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
778, 5esjA, 0.8292, 3.15, 0.148, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
779, 4duaA, 0.8292, 3.17, 0.145, 457, 385, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
780, 3mgxA, 0.8292, 2.90, 0.283, 387, 374, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
781, 5dypC, 0.8291, 3.17, 0.148, 450, 385, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
782, 1p0wB, 0.8291, 3.18, 0.145, 448, 385, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
783, 5esfA, 0.8290, 3.16, 0.150, 524, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
784, 4wg2B, 0.8290, 3.15, 0.154, 451, 384, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
785, 4ck8A, 0.8290, 3.17, 0.172, 449, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
786, 5eafA, 0.8289, 3.15, 0.153, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
787, 5eabA, 0.8289, 3.15, 0.150, 525, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
788, 4zdzA, 0.8289, 3.16, 0.150, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
789, 4dueB, 0.8289, 3.08, 0.146, 450, 383, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
790, 4dueA, 0.8289, 3.08, 0.146, 453, 383, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
791, 4ck8B, 0.8289, 3.15, 0.177, 450, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
792, 2bmhB, 0.8289, 3.16, 0.135, 455, 384, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
793, 1fahB, 0.8289, 3.15, 0.143, 455, 384, STRUCTURE OF CYTOCHROME P450
794, 5esmA, 0.8288, 3.15, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
795, 5eseA, 0.8288, 3.17, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
796, 5eagA, 0.8288, 3.17, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
797, 4wmzA, 0.8288, 3.17, 0.150, 527, 386, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
798, 4hgjB, 0.8288, 3.08, 0.146, 451, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
799, 3qz1C, 0.8288, 2.90, 0.158, 437, 379, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
800, 1p0xB, 0.8288, 3.16, 0.143, 448, 384, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
801, 5ucwA, 0.8287, 3.14, 0.154, 453, 384, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
802, 5b2xA, 0.8287, 3.10, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
803, 4c28A, 0.8287, 3.14, 0.172, 443, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
804, 2ij3B, 0.8287, 3.19, 0.135, 454, 385, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
805, 5ucwB, 0.8286, 3.06, 0.160, 453, 381, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
806, 4zdyA, 0.8286, 3.17, 0.150, 527, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
807, 5li7A, 0.8285, 2.50, 0.345, 373, 365, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
808, 5jqvG, 0.8285, 3.21, 0.148, 451, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
809, 5jqvF, 0.8285, 3.13, 0.141, 455, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
810, 5jquF, 0.8285, 3.12, 0.138, 455, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
811, 5b2yB, 0.8285, 3.09, 0.146, 452, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
812, 5b2xB, 0.8285, 3.09, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
813, 4dufA, 0.8285, 3.14, 0.159, 456, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
814, 2hpdB, 0.8285, 3.18, 0.133, 457, 384, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
815, 5b2vB, 0.8284, 3.09, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
816, 4kewB, 0.8284, 3.10, 0.157, 443, 382, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
817, 4h23A, 0.8284, 3.13, 0.154, 454, 384, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
818, 2x80A, 0.8284, 3.10, 0.159, 455, 383, P450 BM3 F87A IN COMPLEX WITH DMSO
819, 5jlcA, 0.8283, 3.20, 0.153, 506, 386, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
820, 5esnA, 0.8283, 3.17, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
821, 5eqbA, 0.8283, 3.17, 0.150, 531, 386, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
822, 4zfbA, 0.8283, 3.21, 0.140, 460, 385, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
823, 4ze1A, 0.8283, 3.17, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
824, 4ducA, 0.8283, 3.15, 0.154, 456, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
825, 3wspB, 0.8283, 3.09, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
826, 5jquG, 0.8282, 3.06, 0.139, 451, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
827, 2x80B, 0.8282, 3.18, 0.151, 455, 385, P450 BM3 F87A IN COMPLEX WITH DMSO
828, 5jqvE, 0.8281, 3.14, 0.149, 451, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
829, 5hs1A, 0.8281, 3.17, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
830, 5esgA, 0.8281, 3.17, 0.150, 526, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
831, 1zo4B, 0.8281, 3.18, 0.148, 457, 385, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
832, 5eslA, 0.8280, 3.18, 0.150, 527, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
833, 5eaeA, 0.8280, 3.17, 0.150, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
834, 4c27A, 0.8280, 3.15, 0.172, 444, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
835, 3qz1D, 0.8280, 2.90, 0.158, 434, 379, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
836, 1bu7B, 0.8280, 3.19, 0.148, 455, 385, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
837, 5jquE, 0.8279, 3.12, 0.141, 451, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
838, 5eshA, 0.8279, 3.19, 0.150, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
839, 4o4pA, 0.8279, 3.19, 0.159, 450, 384, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
840, 5eahA, 0.8278, 3.18, 0.150, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
841, 5eadA, 0.8278, 3.17, 0.150, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
842, 3wrkD, 0.8278, 2.44, 0.212, 392, 364, CRYSTAL STRUCTURE OF P450CAM
843, 5tz1B, 0.8277, 3.15, 0.151, 484, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
844, 4ze3A, 0.8277, 3.18, 0.150, 526, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
845, 4hghB, 0.8277, 3.13, 0.146, 455, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
846, 4h24A, 0.8277, 3.16, 0.154, 457, 384, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
847, 3ekfA, 0.8277, 3.14, 0.152, 441, 381, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
848, 5e7yB, 0.8276, 3.19, 0.151, 452, 385, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
849, 4ze0A, 0.8276, 3.17, 0.150, 530, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
850, 4dudB, 0.8276, 3.13, 0.143, 456, 384, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
851, 3wspA, 0.8276, 3.11, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
852, 2uvnA, 0.8276, 3.33, 0.271, 399, 377, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
853, 2ij2B, 0.8276, 3.08, 0.144, 448, 383, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
854, 5e9zA, 0.8275, 3.20, 0.145, 452, 385, CYTOCHROME P450 BM3 MUTANT M11
855, 4dubA, 0.8275, 3.19, 0.145, 456, 385, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
856, 2j1mA, 0.8275, 3.14, 0.146, 454, 383, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
857, 1smiA, 0.8275, 3.11, 0.147, 439, 380, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
858, 5og9A, 0.8274, 3.23, 0.153, 454, 385, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
859, 4dudA, 0.8274, 3.16, 0.151, 456, 384, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
860, 2ij2A, 0.8274, 3.22, 0.143, 450, 385, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
861, 5li7B, 0.8273, 2.48, 0.346, 372, 364, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
862, 3qz1B, 0.8273, 2.88, 0.159, 436, 378, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
863, 3dgiA, 0.8273, 3.15, 0.159, 449, 383, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
864, 1bu7A, 0.8273, 3.09, 0.146, 455, 383, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
865, 5ul0A, 0.8272, 3.19, 0.150, 528, 386, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
866, 5eafB, 0.8272, 3.17, 0.153, 528, 386, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
867, 4h24D, 0.8272, 3.15, 0.159, 455, 383, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
868, 4h24B, 0.8272, 3.08, 0.160, 452, 381, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
869, 2hi4A, 0.8272, 3.11, 0.154, 480, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
870, 5jquH, 0.8271, 3.15, 0.133, 450, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
871, 2nzaB, 0.8271, 2.92, 0.325, 388, 375, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
872, 2j1mB, 0.8271, 3.11, 0.146, 454, 383, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
873, 5b2uA, 0.8270, 3.11, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
874, 4ze2A, 0.8270, 3.19, 0.150, 529, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
875, 4hgiB, 0.8270, 3.14, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
876, 4h23B, 0.8270, 3.15, 0.164, 448, 383, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
877, 3g1qD, 0.8270, 3.13, 0.162, 448, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
878, 5xntA, 0.8269, 3.03, 0.264, 392, 375, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
879, 5esiA, 0.8269, 3.19, 0.153, 530, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
880, 2x7yB, 0.8269, 3.13, 0.152, 439, 382, P450 BM3 F87A IN COMPLEX WITH DMSO
881, 2ij3A, 0.8269, 3.15, 0.135, 453, 384, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
882, 5e9zC, 0.8268, 3.23, 0.145, 445, 385, CYTOCHROME P450 BM3 MUTANT M11
883, 4zf8A, 0.8268, 3.20, 0.140, 460, 385, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
884, 5eskA, 0.8267, 3.21, 0.148, 527, 386, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
885, 5b2yA, 0.8267, 3.11, 0.146, 452, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
886, 4zf6A, 0.8267, 3.22, 0.143, 460, 385, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
887, 4dufB, 0.8267, 3.18, 0.154, 456, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
888, 5b2vA, 0.8265, 3.12, 0.146, 453, 383, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
889, 5jq2B, 0.8264, 3.17, 0.146, 459, 384, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
890, 4ducB, 0.8264, 3.16, 0.146, 456, 384, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
891, 4c27B, 0.8264, 3.18, 0.172, 443, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
892, 3l4dB, 0.8264, 3.13, 0.149, 449, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
893, 5jqvH, 0.8263, 3.22, 0.146, 450, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
894, 5ex6C, 0.8263, 2.88, 0.321, 388, 371, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
895, 4hgjA, 0.8263, 3.13, 0.146, 448, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
896, 1fahA, 0.8263, 3.14, 0.144, 455, 383, STRUCTURE OF CYTOCHROME P450
897, 5jtdB, 0.8262, 3.12, 0.146, 458, 383, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
898, 4c28B, 0.8262, 3.20, 0.172, 441, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
899, 3kx5A, 0.8262, 3.12, 0.141, 455, 383, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
900, 3benA, 0.8262, 3.12, 0.146, 454, 383, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
901, 4keyB, 0.8261, 3.22, 0.146, 442, 384, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
902, 3nplB, 0.8261, 3.21, 0.145, 456, 385, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
903, 5e78B, 0.8260, 3.10, 0.144, 454, 383, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
904, 3khmA, 0.8260, 3.21, 0.172, 441, 384, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
905, 5l94B, 0.8259, 1.95, 0.303, 360, 353, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
906, 1yqoB, 0.8259, 3.22, 0.148, 441, 385, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
907, 5v5zA, 0.8257, 3.18, 0.153, 488, 385, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
908, 3g1qB, 0.8257, 3.10, 0.168, 444, 382, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
909, 4dtyB, 0.8256, 3.13, 0.149, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
910, 5e9zB, 0.8255, 3.17, 0.146, 451, 384, CYTOCHROME P450 BM3 MUTANT M11
911, 3kx4A, 0.8255, 3.13, 0.141, 453, 383, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
912, 2hpdA, 0.8255, 3.18, 0.141, 457, 384, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
913, 2bmhA, 0.8255, 3.18, 0.143, 455, 384, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
914, 2x7yA, 0.8254, 3.13, 0.149, 437, 382, P450 BM3 F87A IN COMPLEX WITH DMSO
915, 3wrkA, 0.8253, 2.44, 0.209, 391, 363, CRYSTAL STRUCTURE OF P450CAM
916, 5tz1A, 0.8252, 3.19, 0.156, 484, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
917, 4dtzB, 0.8252, 3.11, 0.149, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
918, 4kpbB, 0.8251, 3.26, 0.143, 444, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
919, 5e7yA, 0.8250, 3.14, 0.144, 451, 383, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
920, 1p0vB, 0.8250, 3.28, 0.140, 444, 385, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
921, 3l4dA, 0.8249, 3.18, 0.149, 448, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
922, 5e78A, 0.8247, 3.18, 0.141, 447, 383, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
923, 4dtwB, 0.8247, 3.15, 0.149, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
924, 3ekfB, 0.8247, 3.11, 0.147, 452, 381, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
925, 5m0oA, 0.8246, 3.06, 0.136, 419, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
926, 4hghA, 0.8246, 3.16, 0.149, 455, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
927, 5fsaA, 0.8245, 3.21, 0.151, 484, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
928, 4jwsB, 0.8245, 2.62, 0.216, 395, 366, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
929, 4by0B, 0.8245, 3.18, 0.172, 442, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
930, 3g1qA, 0.8245, 3.17, 0.162, 448, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
931, 2nnbB, 0.8245, 3.28, 0.140, 441, 386, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
932, 1zo4A, 0.8245, 3.14, 0.146, 456, 383, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
933, 4hgiA, 0.8244, 3.16, 0.149, 455, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
934, 4dubB, 0.8243, 3.12, 0.149, 456, 383, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
935, 4g3jB, 0.8242, 3.17, 0.167, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
936, 4bmmA, 0.8242, 3.22, 0.174, 441, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
937, 3nc3A, 0.8242, 2.38, 0.272, 380, 360, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
938, 4duaB, 0.8241, 3.18, 0.146, 457, 384, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
939, 2wv2A, 0.8241, 3.24, 0.161, 443, 384, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
940, 3benB, 0.8240, 3.18, 0.146, 457, 383, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
941, 3qm4A, 0.8239, 3.40, 0.145, 465, 385, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
942, 3gw9B, 0.8239, 3.18, 0.167, 449, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
943, 3g1qC, 0.8239, 3.16, 0.162, 447, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
944, 4dtwA, 0.8238, 3.15, 0.149, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
945, 3l4dD, 0.8238, 3.18, 0.149, 445, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
946, 5livB, 0.8237, 3.07, 0.248, 389, 379, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
947, 4g7gC, 0.8237, 3.23, 0.161, 448, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
948, 5m0pB, 0.8236, 3.06, 0.136, 421, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
949, 4g3jC, 0.8236, 3.24, 0.161, 448, 384, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
950, 3tdaC, 0.8236, 3.28, 0.148, 467, 384, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
951, 5ex6A, 0.8235, 2.88, 0.328, 386, 369, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
952, 5ajrA, 0.8235, 3.16, 0.172, 449, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
953, 4jwsA, 0.8234, 2.57, 0.219, 392, 366, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
954, 4dtzA, 0.8234, 3.17, 0.144, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
955, 3tbgC, 0.8231, 3.24, 0.144, 467, 383, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
956, 3l4dC, 0.8231, 3.09, 0.150, 447, 380, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
957, 1yqpB, 0.8231, 3.22, 0.143, 441, 384, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
958, 5xw2A, 0.8230, 2.71, 0.359, 375, 365, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
959, 3tikB, 0.8230, 3.18, 0.164, 450, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
960, 4g7gD, 0.8228, 3.17, 0.162, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
961, 4rsnB, 0.8227, 3.22, 0.143, 460, 384, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
962, 4rsnA, 0.8227, 3.22, 0.143, 460, 384, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
963, 3m4vA, 0.8227, 3.15, 0.146, 451, 383, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
964, 5m0pA, 0.8226, 3.12, 0.126, 424, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
965, 5livD, 0.8226, 3.09, 0.251, 389, 378, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
966, 5ikiA, 0.8226, 2.58, 0.266, 383, 364, CYP106A2 WITH SUBSTRATE ABIETIC ACID
967, 4dtyA, 0.8226, 3.17, 0.149, 453, 383, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
968, 3tikC, 0.8226, 3.20, 0.162, 450, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
969, 3gw9D, 0.8226, 3.26, 0.161, 449, 384, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
970, 3gw9A, 0.8225, 3.18, 0.162, 450, 383, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
971, 5fsaB, 0.8224, 3.23, 0.151, 483, 385, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
972, 3tbgA, 0.8224, 3.23, 0.141, 467, 383, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
973, 1jmeB, 0.8224, 3.31, 0.137, 441, 386, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
974, 4ckaA, 0.8223, 3.16, 0.173, 434, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
975, 4ck9A, 0.8223, 3.17, 0.173, 434, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
976, 3tdaA, 0.8223, 3.32, 0.148, 467, 384, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
977, 4wnvA, 0.8222, 3.24, 0.144, 464, 382, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
978, 4g3jD, 0.8222, 3.18, 0.162, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
979, 3p99D, 0.8221, 3.27, 0.164, 448, 384, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
980, 3o1aA, 0.8221, 2.92, 0.331, 383, 369, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
981, 2j4sB, 0.8221, 3.04, 0.153, 450, 379, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
982, 3juvA, 0.8219, 3.41, 0.155, 448, 386, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
983, 2nnbA, 0.8219, 3.16, 0.144, 441, 383, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
984, 4by0A, 0.8218, 3.22, 0.175, 441, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
985, 2p85B, 0.8218, 3.20, 0.162, 464, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
986, 1p0vA, 0.8218, 3.18, 0.141, 441, 383, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
987, 4bmmB, 0.8217, 3.25, 0.172, 442, 384, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
988, 5tftB, 0.8216, 3.26, 0.144, 460, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
989, 4bmmC, 0.8216, 3.29, 0.172, 440, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
990, 3zg2A, 0.8216, 3.18, 0.175, 449, 383, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
991, 1yqoA, 0.8216, 3.18, 0.146, 441, 383, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
992, 3nc6A, 0.8215, 2.19, 0.277, 374, 357, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
993, 2x2nA, 0.8215, 3.26, 0.161, 448, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
994, 5tftA, 0.8214, 3.28, 0.144, 467, 383, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
995, 4ejhG, 0.8214, 3.21, 0.165, 463, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
996, 2x9pA, 0.8212, 2.98, 0.300, 385, 370, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
997, 3vooA, 0.8211, 3.24, 0.173, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
998, 3qm4B, 0.8211, 3.43, 0.145, 457, 385, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
999, 3awqA, 0.8211, 3.25, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
1000, 5m0nA, 0.8209, 3.12, 0.136, 423, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
1001, 2zqjB, 0.8209, 3.17, 0.139, 411, 382, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
1002, 5yhjB, 0.8208, 3.03, 0.161, 411, 378, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
1003, 4xrzB, 0.8208, 3.42, 0.151, 458, 385, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1004, 4g7gA, 0.8208, 3.21, 0.162, 448, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
1005, 4l54A, 0.8207, 3.12, 0.136, 419, 381, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
1006, 2x2nD, 0.8207, 3.27, 0.161, 447, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1007, 1p0xA, 0.8207, 3.19, 0.144, 441, 383, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
1008, 3tikA, 0.8206, 3.21, 0.162, 450, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1009, 4l40A, 0.8205, 3.13, 0.136, 419, 381, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
1010, 3vtjA, 0.8205, 3.27, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
1011, 3awpA, 0.8205, 3.27, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
1012, 3tikD, 0.8204, 3.24, 0.164, 450, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
1013, 2q9fA, 0.8204, 2.93, 0.168, 433, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
1014, 1yqpA, 0.8204, 3.19, 0.144, 441, 383, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
1015, 2zqxC, 0.8203, 3.17, 0.139, 411, 382, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
1016, 6b82B, 0.8202, 3.28, 0.167, 470, 384, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1017, 4du2B, 0.8202, 3.23, 0.146, 444, 383, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
1018, 4yt3A, 0.8201, 2.78, 0.269, 388, 368, CYP106A2
1019, 4kf2A, 0.8201, 3.44, 0.148, 451, 385, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
1020, 1p0wA, 0.8201, 3.20, 0.144, 441, 383, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
1021, 1jmeA, 0.8201, 3.20, 0.141, 441, 383, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
1022, 5kyoD, 0.8200, 2.78, 0.203, 384, 370, CRYSTAL STRUCTURE OF CYP101J2
1023, 2zqxB, 0.8200, 3.18, 0.139, 411, 382, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
1024, 2zqjC, 0.8200, 3.11, 0.139, 411, 381, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
1025, 1izoA, 0.8200, 3.17, 0.134, 411, 382, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
1026, 5uhuA, 0.8199, 3.23, 0.372, 393, 379, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
1027, 2j4sA, 0.8199, 3.23, 0.144, 452, 383, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
1028, 4yt3B, 0.8198, 2.79, 0.266, 388, 368, CYP106A2
1029, 3vm4A, 0.8198, 3.26, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
1030, 6cizA, 0.8197, 3.40, 0.169, 468, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1031, 2x2nC, 0.8197, 3.27, 0.161, 441, 384, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1032, 6cizB, 0.8195, 3.38, 0.166, 469, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1033, 3vnoA, 0.8195, 3.27, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
1034, 6aycA, 0.8194, 3.32, 0.172, 449, 384, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
1035, 5uysB, 0.8194, 3.38, 0.166, 470, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1036, 5uysA, 0.8194, 3.39, 0.166, 471, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1037, 5m0oC, 0.8194, 3.16, 0.126, 421, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
1038, 4wnwA, 0.8193, 3.47, 0.140, 461, 385, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
1039, 4kpbA, 0.8193, 3.31, 0.143, 440, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
1040, 3nc5B, 0.8193, 2.22, 0.275, 373, 356, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1041, 6chiB, 0.8192, 3.40, 0.164, 468, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1042, 6chiA, 0.8192, 3.39, 0.169, 466, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1043, 3awmA, 0.8192, 3.29, 0.170, 407, 382, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
1044, 4bmmD, 0.8191, 3.29, 0.172, 442, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
1045, 2zqjA, 0.8190, 3.20, 0.136, 411, 382, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
1046, 4i8vB, 0.8189, 3.34, 0.148, 472, 384, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1047, 3p99A, 0.8188, 3.32, 0.164, 448, 384, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1048, 3ekdA, 0.8188, 3.32, 0.148, 454, 384, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1049, 1izoB, 0.8188, 3.20, 0.139, 411, 382, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
1050, 5mnvG, 0.8187, 2.71, 0.353, 380, 368, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1051, 4du2A, 0.8187, 3.24, 0.154, 443, 383, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
1052, 2x2nB, 0.8187, 3.25, 0.162, 444, 383, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
1053, 5uysD, 0.8186, 3.23, 0.154, 473, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1054, 3zg3A, 0.8185, 3.20, 0.175, 445, 382, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
1055, 4uvrA, 0.8183, 3.32, 0.174, 439, 384, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
1056, 4bjkC, 0.8183, 3.32, 0.161, 450, 384, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1057, 3p99B, 0.8183, 3.22, 0.162, 448, 382, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1058, 2zqxA, 0.8183, 3.22, 0.136, 411, 382, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
1059, 5kyoF, 0.8182, 2.74, 0.207, 383, 368, CRYSTAL STRUCTURE OF CYP101J2
1060, 2fdwC, 0.8182, 3.29, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1061, 6b82A, 0.8181, 3.21, 0.160, 465, 381, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
1062, 4bjkD, 0.8181, 3.29, 0.161, 444, 384, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1063, 2pg5C, 0.8181, 3.28, 0.172, 463, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1064, 4h6oA, 0.8180, 3.23, 0.170, 435, 383, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
1065, 1izoC, 0.8180, 3.22, 0.139, 411, 382, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
1066, 5irqB, 0.8179, 3.43, 0.166, 467, 385, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1067, 6fshD, 0.8178, 3.03, 0.291, 382, 368, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1068, 3oo3A, 0.8178, 2.63, 0.331, 371, 362, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1069, 2fdyC, 0.8178, 3.29, 0.172, 464, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1070, 1bvyA, 0.8178, 3.16, 0.150, 439, 379, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
1071, 4cohB, 0.8177, 3.25, 0.172, 445, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1072, 5uysC, 0.8176, 3.32, 0.162, 473, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
1073, 4nkwA, 0.8176, 3.40, 0.159, 464, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1074, 4cohA, 0.8176, 3.24, 0.172, 442, 383, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
1075, 3m4vB, 0.8176, 3.25, 0.144, 438, 383, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
1076, 5e9zD, 0.8175, 3.41, 0.148, 444, 385, CYTOCHROME P450 BM3 MUTANT M11
1077, 4nkwB, 0.8174, 3.38, 0.164, 464, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1078, 4ejgG, 0.8174, 3.24, 0.168, 463, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1079, 2pg7C, 0.8174, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1080, 3p99C, 0.8173, 3.22, 0.165, 444, 382, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
1081, 3ekdB, 0.8173, 3.26, 0.141, 455, 383, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
1082, 1z11C, 0.8173, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1083, 4nkvA, 0.8172, 3.43, 0.166, 466, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1084, 4i8vD, 0.8172, 3.24, 0.150, 467, 381, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1085, 3rukD, 0.8171, 3.24, 0.160, 473, 382, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1086, 1z10C, 0.8171, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1087, 6ay4A, 0.8170, 3.33, 0.169, 450, 384, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
1088, 5irqC, 0.8170, 3.33, 0.162, 472, 383, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1089, 4bjkB, 0.8170, 3.35, 0.161, 450, 384, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1090, 4xrzA, 0.8169, 3.50, 0.145, 457, 385, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1091, 3rukB, 0.8169, 3.45, 0.166, 465, 385, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1092, 2fdvC, 0.8169, 3.30, 0.172, 464, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1093, 4xryA, 0.8168, 3.31, 0.144, 464, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1094, 2pg6C, 0.8168, 3.30, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1095, 6chiC, 0.8167, 3.29, 0.157, 476, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1096, 4i8vA, 0.8167, 3.42, 0.151, 477, 385, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1097, 6cizC, 0.8166, 3.27, 0.162, 477, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1098, 5irqA, 0.8166, 3.40, 0.159, 466, 384, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1099, 3rukA, 0.8166, 3.38, 0.161, 464, 384, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1100, 4kf0A, 0.8165, 3.45, 0.151, 451, 384, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1101, 2fduC, 0.8165, 3.30, 0.172, 464, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1102, 4hggB, 0.8164, 3.39, 0.154, 441, 383, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1103, 3mdmA, 0.8164, 3.07, 0.167, 435, 377, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
1104, 4z5qA, 0.8163, 2.50, 0.338, 363, 358, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1105, 4kf2B, 0.8162, 3.43, 0.151, 448, 384, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
1106, 4bjkA, 0.8162, 3.34, 0.161, 450, 384, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
1107, 4nkyA, 0.8161, 3.41, 0.156, 462, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1108, 4nkvB, 0.8161, 3.46, 0.166, 467, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1109, 2fdwD, 0.8161, 3.34, 0.175, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1110, 1bvyB, 0.8161, 3.16, 0.151, 438, 378, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
1111, 6ay6A, 0.8160, 3.34, 0.172, 448, 383, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
1112, 4i8vC, 0.8160, 3.35, 0.149, 468, 383, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
1113, 3swzA, 0.8160, 3.43, 0.166, 471, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1114, 2fdwB, 0.8160, 3.37, 0.172, 465, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1115, 6cirA, 0.8159, 3.46, 0.166, 466, 385, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1116, 4wnvC, 0.8159, 3.28, 0.145, 454, 379, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1117, 2nnhB, 0.8159, 3.18, 0.163, 463, 381, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
1118, 5irvA, 0.8158, 3.40, 0.161, 471, 384, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1119, 4wnwB, 0.8158, 3.51, 0.141, 452, 384, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
1120, 4nkxB, 0.8158, 3.39, 0.156, 468, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1121, 3tdaD, 0.8157, 3.32, 0.152, 456, 382, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1122, 2pg7B, 0.8157, 3.37, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1123, 6chiD, 0.8156, 3.32, 0.154, 467, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
1124, 1z11B, 0.8156, 3.36, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1125, 6cirB, 0.8155, 3.42, 0.159, 466, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1126, 4nkxA, 0.8155, 3.40, 0.156, 466, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1127, 4nkvC, 0.8155, 3.37, 0.162, 471, 383, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1128, 6cizD, 0.8154, 3.32, 0.154, 468, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
1129, 4fxbB, 0.8154, 2.55, 0.361, 370, 360, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1130, 4ejhH, 0.8154, 3.29, 0.160, 459, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1131, 4c0cA, 0.8154, 3.37, 0.174, 446, 385, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1132, 4nkyB, 0.8153, 3.48, 0.158, 464, 385, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1133, 3tdaB, 0.8153, 3.41, 0.146, 456, 383, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
1134, 3t3rA, 0.8153, 3.33, 0.175, 463, 383, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1135, 3swzB, 0.8153, 3.42, 0.159, 465, 384, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1136, 3ebsC, 0.8153, 3.33, 0.175, 464, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1137, 5irvB, 0.8152, 3.34, 0.162, 471, 383, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1138, 5a1pA, 0.8152, 3.23, 0.207, 465, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
1139, 3t3qD, 0.8152, 3.33, 0.172, 463, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1140, 2uvnB, 0.8151, 3.35, 0.280, 391, 372, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1141, 2fduD, 0.8151, 3.35, 0.175, 464, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1142, 4ejhE, 0.8149, 3.25, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1143, 3t3qC, 0.8149, 3.28, 0.176, 463, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1144, 3qi8B, 0.8149, 3.27, 0.155, 452, 380, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1145, 2pg5D, 0.8149, 3.35, 0.175, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1146, 1z10D, 0.8149, 3.35, 0.175, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1147, 2nnhA, 0.8148, 3.21, 0.160, 463, 381, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
1148, 1z11D, 0.8148, 3.35, 0.175, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1149, 5yhjA, 0.8147, 3.06, 0.162, 406, 376, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
1150, 5ex9A, 0.8147, 3.40, 0.286, 414, 377, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1151, 5ex8A, 0.8147, 3.35, 0.287, 414, 376, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1152, 2wx2A, 0.8146, 3.47, 0.174, 441, 384, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1153, 2pg5B, 0.8146, 3.38, 0.172, 464, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1154, 1lgfA, 0.8146, 3.19, 0.278, 388, 371, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1155, 5tfuB, 0.8145, 3.33, 0.145, 451, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1156, 3tbgB, 0.8145, 3.32, 0.144, 456, 381, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1157, 4xrzD, 0.8144, 3.36, 0.150, 455, 381, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1158, 2pg6B, 0.8144, 3.35, 0.170, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1159, 3rukC, 0.8143, 3.23, 0.157, 472, 381, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
1160, 2fdvD, 0.8143, 3.31, 0.175, 464, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1161, 6cirC, 0.8142, 3.32, 0.160, 472, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1162, 5irvD, 0.8142, 3.32, 0.157, 472, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1163, 4tx3A, 0.8142, 2.65, 0.316, 373, 361, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1164, 4ruiA, 0.8142, 3.28, 0.175, 464, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1165, 4nkyC, 0.8142, 3.31, 0.154, 467, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1166, 3tbgD, 0.8142, 3.36, 0.144, 456, 382, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
1167, 2pg6D, 0.8142, 3.31, 0.175, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1168, 3swzC, 0.8141, 3.33, 0.157, 470, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1169, 1z10B, 0.8141, 3.39, 0.172, 465, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1170, 1og5B, 0.8141, 3.21, 0.178, 461, 381, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1171, 4xryB, 0.8140, 3.47, 0.146, 455, 383, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1172, 6cirD, 0.8138, 3.34, 0.154, 471, 382, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
1173, 4wnvB, 0.8138, 3.32, 0.142, 455, 380, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1174, 4wntA, 0.8138, 3.51, 0.146, 457, 384, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1175, 4nkzB, 0.8138, 3.45, 0.156, 461, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1176, 2vn0A, 0.8138, 3.21, 0.163, 464, 381, CYP2C8DH COMPLEXED WITH TROGLITAZONE
1177, 2fduB, 0.8138, 3.39, 0.172, 463, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1178, 1z11A, 0.8138, 3.35, 0.170, 467, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
1179, 1se6A, 0.8138, 2.89, 0.322, 384, 369, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1180, 4nkzA, 0.8137, 3.45, 0.156, 463, 384, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1181, 4nkxC, 0.8137, 3.33, 0.154, 469, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1182, 4j14A, 0.8137, 3.15, 0.167, 436, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
1183, 3t3qB, 0.8137, 3.35, 0.170, 463, 382, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1184, 3mdrA, 0.8137, 3.06, 0.168, 427, 376, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
1185, 3hf2A, 0.8137, 3.35, 0.142, 428, 381, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1186, 4xrzC, 0.8136, 3.41, 0.149, 455, 382, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
1187, 4ejjA, 0.8136, 3.36, 0.175, 465, 383, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1188, 5ysmA, 0.8135, 2.31, 0.385, 364, 356, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1189, 5e0eA, 0.8135, 3.25, 0.152, 463, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1190, 4nkwD, 0.8135, 3.37, 0.154, 467, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1191, 4ejiA, 0.8135, 3.28, 0.168, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
1192, 3ebsB, 0.8135, 3.39, 0.172, 466, 383, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1193, 2ve4A, 0.8135, 3.22, 0.203, 431, 379, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1194, 2pg7D, 0.8135, 3.31, 0.175, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1195, 1og5A, 0.8135, 3.22, 0.186, 461, 381, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1196, 5irvC, 0.8134, 3.33, 0.157, 475, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
1197, 5a1rA, 0.8134, 3.22, 0.210, 462, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
1198, 4uqhA, 0.8134, 3.41, 0.171, 443, 385, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
1199, 4ejhC, 0.8134, 3.25, 0.160, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1200, 1tqnA, 0.8134, 3.32, 0.204, 468, 383, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
1201, 5tl8A, 0.8133, 3.36, 0.173, 448, 382, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
1202, 3mdrB, 0.8133, 3.07, 0.168, 425, 376, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
1203, 4ejgH, 0.8132, 3.37, 0.157, 458, 383, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1204, 1og2A, 0.8132, 3.23, 0.178, 461, 381, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1205, 4ejhD, 0.8131, 3.30, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1206, 4ejgA, 0.8131, 3.26, 0.163, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1207, 2fdwA, 0.8131, 3.30, 0.171, 465, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1208, 5irqD, 0.8130, 3.35, 0.160, 465, 382, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
1209, 4ruiB, 0.8130, 3.30, 0.175, 465, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1210, 4r21B, 0.8130, 3.16, 0.173, 423, 376, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
1211, 4nz2A, 0.8130, 3.22, 0.178, 464, 381, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
1212, 4gqsA, 0.8130, 3.26, 0.188, 464, 382, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1213, 4ejgE, 0.8130, 3.27, 0.162, 465, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1214, 2ve4B, 0.8130, 3.26, 0.211, 432, 379, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
1215, 2pg7A, 0.8130, 3.31, 0.171, 464, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
1216, 2fdvB, 0.8130, 3.40, 0.172, 465, 383, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1217, 4wnvD, 0.8129, 3.28, 0.145, 453, 379, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
1218, 4ruiF, 0.8129, 3.30, 0.175, 465, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1219, 1suoA, 0.8129, 3.37, 0.170, 465, 383, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
1220, 4ruiE, 0.8128, 3.30, 0.175, 465, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1221, 4ejjC, 0.8128, 3.35, 0.173, 464, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1222, 3t3qA, 0.8128, 3.32, 0.175, 463, 382, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
1223, 3ibdA, 0.8128, 3.33, 0.159, 465, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
1224, 3ebsD, 0.8128, 3.32, 0.175, 464, 382, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1225, 4ruiD, 0.8127, 3.36, 0.172, 465, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1226, 4ejjB, 0.8127, 3.38, 0.175, 464, 383, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1227, 2pg5A, 0.8127, 3.37, 0.170, 464, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
1228, 2fdyD, 0.8127, 3.33, 0.175, 464, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1229, 1og2B, 0.8127, 3.22, 0.178, 461, 381, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
1230, 4kf0B, 0.8126, 3.47, 0.149, 441, 382, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
1231, 4gqsB, 0.8126, 3.23, 0.192, 456, 381, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1232, 4ejhA, 0.8126, 3.30, 0.168, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1233, 3t3rC, 0.8126, 3.32, 0.175, 463, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1234, 3t3sC, 0.8125, 3.31, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1235, 2fduA, 0.8125, 3.37, 0.170, 465, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
1236, 6fshA, 0.8124, 2.91, 0.297, 378, 364, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1237, 5tfuD, 0.8124, 3.37, 0.145, 453, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1238, 2fdvA, 0.8123, 3.38, 0.170, 465, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
1239, 6aybA, 0.8122, 3.32, 0.173, 447, 381, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
1240, 1z10A, 0.8121, 3.38, 0.170, 465, 382, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
1241, 4nkwC, 0.8120, 3.31, 0.157, 467, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
1242, 4ejhF, 0.8120, 3.32, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1243, 4ejgC, 0.8120, 3.28, 0.163, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1244, 4ruiC, 0.8119, 3.32, 0.175, 464, 382, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
1245, 4nz2B, 0.8119, 3.24, 0.178, 464, 381, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
1246, 4nkvD, 0.8119, 3.37, 0.157, 466, 382, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
1247, 4fiaA, 0.8119, 3.12, 0.167, 426, 377, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
1248, 4e2pA, 0.8119, 2.57, 0.344, 370, 358, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1249, 2nniA, 0.8119, 3.25, 0.160, 463, 381, CYP2C8DH COMPLEXED WITH MONTELUKAST
1250, 4ejhB, 0.8118, 3.31, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
1251, 3t3rD, 0.8118, 3.39, 0.170, 464, 382, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1252, 4nkxD, 0.8117, 3.30, 0.155, 468, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
1253, 4hgfB, 0.8117, 3.46, 0.152, 441, 381, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1254, 1nr6A, 0.8117, 3.31, 0.164, 462, 383, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
1255, 4nkyD, 0.8116, 3.35, 0.152, 465, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
1256, 3t3rB, 0.8116, 3.31, 0.171, 463, 381, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
1257, 1io9A, 0.8116, 2.37, 0.295, 366, 353, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1258, 3mdvB, 0.8115, 3.07, 0.168, 424, 375, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
1259, 3mdvA, 0.8115, 3.07, 0.168, 424, 375, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
1260, 6bczA, 0.8114, 3.19, 0.213, 461, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1261, 3ebsA, 0.8114, 3.31, 0.171, 465, 381, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
1262, 2pg6A, 0.8114, 3.32, 0.171, 465, 381, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
1263, 2p85E, 0.8114, 3.33, 0.165, 464, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1264, 1n6bA, 0.8113, 3.36, 0.169, 462, 384, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
1265, 3t3sD, 0.8112, 3.28, 0.160, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1266, 3swzD, 0.8111, 3.33, 0.160, 466, 381, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
1267, 6fshB, 0.8110, 3.05, 0.287, 380, 366, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1268, 2nnjA, 0.8110, 3.26, 0.165, 463, 381, CYP2C8DH COMPLEXED WITH FELODIPINE
1269, 2fdyA, 0.8110, 3.32, 0.171, 465, 381, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1270, 4ejgB, 0.8109, 3.32, 0.168, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1271, 6bdiA, 0.8108, 3.13, 0.214, 462, 378, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1272, 5veuI, 0.8108, 3.31, 0.186, 464, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1273, 4gqsC, 0.8108, 3.25, 0.186, 462, 381, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1274, 4ejgD, 0.8108, 3.34, 0.168, 465, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1275, 1pq2A, 0.8108, 3.26, 0.163, 463, 381, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
1276, 5tftD, 0.8107, 3.38, 0.145, 453, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1277, 4hggA, 0.8107, 3.33, 0.158, 435, 379, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1278, 4i3qA, 0.8106, 3.24, 0.207, 465, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
1279, 4hgfA, 0.8106, 3.45, 0.157, 442, 381, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
1280, 4ejjD, 0.8106, 3.40, 0.172, 464, 383, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
1281, 5a5jA, 0.8105, 3.42, 0.185, 455, 384, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1282, 4nkzC, 0.8105, 3.33, 0.157, 464, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1283, 3ua5A, 0.8105, 3.29, 0.162, 465, 382, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1284, 1pq2B, 0.8105, 3.27, 0.163, 463, 381, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
1285, 3t3sB, 0.8103, 3.35, 0.165, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1286, 2p85C, 0.8103, 3.32, 0.165, 464, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1287, 6fshC, 0.8102, 3.08, 0.287, 380, 366, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1288, 5tfuC, 0.8102, 3.41, 0.145, 450, 380, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1289, 3t3sA, 0.8102, 3.33, 0.168, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1290, 5veuC, 0.8101, 3.35, 0.186, 469, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1291, 4ejgF, 0.8101, 3.34, 0.165, 465, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
1292, 3ua5B, 0.8101, 3.26, 0.150, 462, 381, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
1293, 6bd7A, 0.8100, 3.23, 0.213, 462, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1294, 4wntB, 0.8100, 3.43, 0.150, 455, 381, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
1295, 4nkzD, 0.8100, 3.34, 0.157, 465, 381, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
1296, 3me6A, 0.8099, 3.35, 0.178, 465, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1297, 3me6C, 0.8098, 3.41, 0.172, 465, 383, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1298, 1r9oA, 0.8098, 3.42, 0.185, 455, 384, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
1299, 6bdkA, 0.8097, 3.15, 0.217, 461, 378, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1300, 3me6D, 0.8097, 3.35, 0.178, 465, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1301, 2fdyB, 0.8097, 3.43, 0.170, 464, 382, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
1302, 4enhA, 0.8096, 3.10, 0.168, 426, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
1303, 1io8A, 0.8096, 2.40, 0.295, 366, 353, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1304, 1io7A, 0.8096, 2.40, 0.295, 366, 353, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1305, 4d75A, 0.8095, 3.24, 0.207, 460, 381, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1306, 3me6B, 0.8095, 3.42, 0.172, 465, 383, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
1307, 3tk3B, 0.8093, 3.42, 0.172, 465, 383, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1308, 3dgiB, 0.8093, 3.04, 0.151, 425, 372, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
1309, 2p85D, 0.8092, 3.35, 0.165, 464, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1310, 3tk3A, 0.8091, 3.42, 0.172, 465, 383, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1311, 3ua1A, 0.8090, 3.27, 0.213, 456, 380, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
1312, 3tk3D, 0.8090, 3.43, 0.172, 465, 383, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1313, 3mdtB, 0.8090, 3.09, 0.168, 424, 375, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1314, 3lc4A, 0.8090, 3.36, 0.181, 460, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1315, 3kohB, 0.8090, 3.35, 0.181, 463, 381, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1316, 5tfuA, 0.8089, 3.34, 0.149, 451, 377, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1317, 4r21A, 0.8089, 3.16, 0.179, 422, 374, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
1318, 5vcgA, 0.8088, 3.28, 0.213, 461, 380, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
1319, 3tk3C, 0.8088, 3.43, 0.172, 465, 383, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
1320, 3b4xA, 0.8088, 2.56, 0.297, 367, 353, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1321, 6bd8A, 0.8086, 3.13, 0.218, 457, 377, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1322, 4xryD, 0.8086, 3.36, 0.148, 452, 378, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1323, 5k7kA, 0.8085, 3.46, 0.187, 455, 384, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
1324, 4wnuD, 0.8085, 3.29, 0.142, 450, 379, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1325, 3kohA, 0.8085, 3.36, 0.181, 463, 381, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
1326, 3t3sF, 0.8082, 3.39, 0.162, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1327, 2q6nG, 0.8082, 3.41, 0.178, 465, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1328, 2q9gA, 0.8078, 3.15, 0.168, 422, 375, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
1329, 1lg9A, 0.8078, 2.80, 0.281, 377, 360, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1330, 3qu8A, 0.8077, 3.37, 0.162, 462, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1331, 3na0A, 0.8077, 3.44, 0.158, 470, 385, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1332, 5vccA, 0.8076, 3.33, 0.213, 457, 381, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
1333, 4wnuB, 0.8076, 3.27, 0.143, 453, 378, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1334, 3uasA, 0.8076, 3.46, 0.172, 461, 383, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
1335, 3na0B, 0.8076, 3.42, 0.156, 470, 384, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
1336, 5x23A, 0.8075, 3.32, 0.181, 463, 381, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1337, 4wnuA, 0.8075, 3.28, 0.146, 449, 377, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1338, 3t3sE, 0.8075, 3.33, 0.163, 464, 381, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1339, 6bd5A, 0.8074, 3.29, 0.211, 457, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1340, 3na1A, 0.8074, 3.45, 0.158, 472, 385, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1341, 3lc4B, 0.8074, 3.38, 0.181, 459, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
1342, 2p85F, 0.8074, 3.36, 0.163, 464, 381, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1343, 5vcdA, 0.8073, 3.29, 0.213, 460, 380, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
1344, 3na1B, 0.8073, 3.43, 0.156, 471, 384, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
1345, 3mdtA, 0.8073, 3.13, 0.168, 424, 375, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
1346, 3e6iA, 0.8073, 3.38, 0.181, 462, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1347, 2p85A, 0.8073, 3.38, 0.162, 464, 382, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
1348, 5iuzB, 0.8072, 3.45, 0.170, 464, 382, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1349, 3t3zA, 0.8072, 3.35, 0.181, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1350, 3t3zB, 0.8070, 3.35, 0.181, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1351, 3t3sH, 0.8070, 3.46, 0.160, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1352, 3t3sG, 0.8070, 3.39, 0.168, 464, 382, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
1353, 3e6iB, 0.8070, 3.38, 0.181, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
1354, 4wnuC, 0.8069, 3.26, 0.143, 452, 377, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
1355, 3tmzA, 0.8069, 3.35, 0.173, 463, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
1356, 5xxiA, 0.8068, 3.33, 0.176, 463, 381, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1357, 5te8B, 0.8068, 3.30, 0.195, 471, 380, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1358, 5tftC, 0.8067, 3.42, 0.145, 447, 379, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1359, 3n9yB, 0.8067, 3.43, 0.156, 470, 384, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1360, 3n9yA, 0.8067, 3.46, 0.158, 471, 385, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
1361, 3e4eA, 0.8067, 3.38, 0.181, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1362, 5wbgB, 0.8066, 3.42, 0.162, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1363, 5e58D, 0.8066, 3.49, 0.162, 463, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1364, 3n9zA, 0.8066, 3.46, 0.158, 470, 385, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1365, 5iuzA, 0.8064, 3.46, 0.173, 459, 382, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
1366, 3t3zC, 0.8064, 3.36, 0.181, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1367, 3r1aC, 0.8064, 3.50, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1368, 3n9zB, 0.8064, 3.43, 0.156, 470, 384, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
1369, 3e4eB, 0.8064, 3.38, 0.181, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
1370, 5e58A, 0.8062, 3.43, 0.157, 464, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1371, 3qu8C, 0.8062, 3.40, 0.165, 462, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1372, 2q6nF, 0.8062, 3.44, 0.175, 465, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1373, 5wbgC, 0.8060, 3.43, 0.162, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1374, 5wbgF, 0.8059, 3.43, 0.162, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1375, 5te8A, 0.8059, 3.34, 0.207, 470, 381, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1376, 4xryC, 0.8059, 3.41, 0.146, 446, 378, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
1377, 3qu8B, 0.8059, 3.37, 0.163, 459, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1378, 4ny4A, 0.8058, 3.32, 0.205, 460, 380, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
1379, 3t3zD, 0.8058, 3.37, 0.181, 464, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
1380, 1w0fA, 0.8058, 3.26, 0.209, 459, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1381, 5x24A, 0.8057, 3.27, 0.179, 463, 380, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
1382, 5wbgA, 0.8057, 3.43, 0.162, 463, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1383, 5veuF, 0.8057, 3.39, 0.195, 456, 380, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1384, 3r1aG, 0.8057, 3.52, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1385, 3gphA, 0.8057, 3.42, 0.181, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1386, 5vceA, 0.8056, 3.25, 0.211, 457, 379, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
1387, 3gphB, 0.8056, 3.39, 0.181, 461, 381, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
1388, 6bdmA, 0.8055, 3.10, 0.219, 456, 375, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1389, 5wbgD, 0.8055, 3.44, 0.162, 464, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1390, 4k9vA, 0.8055, 3.14, 0.210, 456, 376, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1391, 3hf2B, 0.8055, 3.25, 0.141, 423, 375, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
1392, 5wbgE, 0.8053, 3.43, 0.162, 463, 382, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
1393, 5ex6B, 0.8053, 2.68, 0.330, 371, 358, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1394, 5e58B, 0.8053, 3.51, 0.159, 458, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1395, 3qu8E, 0.8053, 3.37, 0.163, 459, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1396, 3qu8D, 0.8053, 3.38, 0.163, 458, 381, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1397, 2q6nB, 0.8053, 3.44, 0.175, 465, 382, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1398, 5veuB, 0.8052, 3.33, 0.198, 458, 379, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1399, 2wx2B, 0.8052, 3.50, 0.175, 444, 383, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
1400, 5iutA, 0.8051, 3.36, 0.176, 460, 380, STRUCTURE OF P450 2B4 F202W MUTANT
1401, 4k9tA, 0.8051, 3.19, 0.204, 455, 377, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1402, 3r1aH, 0.8051, 3.52, 0.175, 464, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1403, 5e58C, 0.8049, 3.51, 0.162, 465, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1404, 3r1aD, 0.8049, 3.53, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1405, 3mzsC, 0.8049, 3.50, 0.158, 470, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1406, 3kw4A, 0.8049, 3.48, 0.168, 466, 382, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
1407, 2v0mC, 0.8049, 3.48, 0.206, 465, 383, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1408, 6bd6A, 0.8048, 3.21, 0.212, 457, 378, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1409, 3mzsD, 0.8048, 3.46, 0.156, 470, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1410, 5veuH, 0.8047, 3.31, 0.201, 459, 379, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1411, 5e58E, 0.8046, 3.47, 0.157, 462, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1412, 4d6zA, 0.8046, 3.27, 0.212, 460, 378, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
1413, 5w0cA, 0.8045, 3.31, 0.188, 464, 378, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
1414, 3qoaA, 0.8044, 3.45, 0.165, 460, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
1415, 1ue8A, 0.8044, 2.63, 0.297, 367, 353, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1416, 5veuD, 0.8042, 3.36, 0.206, 459, 379, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1417, 4zv8A, 0.8042, 3.45, 0.162, 465, 382, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
1418, 2q6nC, 0.8041, 3.51, 0.170, 465, 383, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1419, 3mzsB, 0.8040, 3.51, 0.158, 470, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1420, 5g5jA, 0.8038, 3.21, 0.210, 452, 376, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
1421, 4tuvA, 0.8038, 2.67, 0.292, 367, 353, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1422, 1dt6A, 0.8038, 3.44, 0.159, 449, 383, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
1423, 5a5iA, 0.8037, 3.49, 0.180, 453, 383, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
1424, 4wqjA, 0.8037, 2.67, 0.292, 367, 353, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1425, 5veuJ, 0.8035, 3.48, 0.192, 458, 381, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1426, 5veuA, 0.8034, 3.28, 0.188, 462, 378, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1427, 4rqlB, 0.8034, 3.46, 0.165, 465, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1428, 3r1aF, 0.8033, 3.54, 0.170, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1429, 4rqlA, 0.8031, 3.53, 0.159, 465, 383, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
1430, 5uapA, 0.8030, 3.47, 0.165, 464, 382, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1431, 1f4tB, 0.8029, 2.68, 0.293, 367, 352, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1432, 3r1aA, 0.8028, 3.54, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1433, 4h1nA, 0.8027, 3.46, 0.171, 459, 380, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
1434, 3mzsA, 0.8027, 3.53, 0.158, 470, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
1435, 5te8C, 0.8026, 3.33, 0.208, 469, 379, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
1436, 3r1aE, 0.8026, 3.49, 0.178, 465, 382, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1437, 5udaA, 0.8025, 3.41, 0.163, 461, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1438, 4rrtB, 0.8025, 3.47, 0.165, 461, 382, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1439, 5uapB, 0.8024, 3.41, 0.165, 463, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
1440, 4tt5A, 0.8024, 2.69, 0.292, 367, 353, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1441, 2q6nA, 0.8024, 3.56, 0.170, 465, 383, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1442, 5veuG, 0.8023, 3.39, 0.177, 455, 379, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1443, 4jltA, 0.8023, 3.48, 0.168, 458, 381, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
1444, 4rrtA, 0.8022, 3.53, 0.162, 461, 383, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
1445, 4kq8A, 0.8021, 3.55, 0.148, 452, 384, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
1446, 1lfkA, 0.8021, 3.02, 0.279, 375, 362, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1447, 5udaB, 0.8020, 3.42, 0.165, 460, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
1448, 4wpdB, 0.8020, 2.67, 0.290, 367, 352, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1449, 3r1aB, 0.8017, 3.56, 0.172, 465, 383, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1450, 2q6nD, 0.8015, 3.55, 0.170, 465, 383, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1451, 4i91A, 0.8014, 3.48, 0.165, 465, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
1452, 5vc0A, 0.8013, 3.41, 0.189, 463, 380, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
1453, 5uecA, 0.8012, 3.44, 0.165, 465, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
1454, 5jl9A, 0.8010, 3.51, 0.154, 452, 382, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
1455, 3mvrB, 0.8010, 3.47, 0.171, 463, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1456, 1f4tA, 0.8010, 2.67, 0.293, 367, 352, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1457, 4r20B, 0.8009, 3.34, 0.176, 414, 374, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1458, 3mvrA, 0.8009, 3.47, 0.171, 463, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
1459, 2q6nE, 0.8006, 3.59, 0.170, 465, 383, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
1460, 4i4gA, 0.8004, 3.34, 0.193, 459, 378, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
1461, 4i4hA, 0.8003, 3.35, 0.195, 457, 379, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
1462, 3s79A, 0.8002, 3.54, 0.157, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
1463, 1io8B, 0.8002, 2.36, 0.300, 359, 347, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1464, 5ufgA, 0.7999, 3.45, 0.165, 464, 381, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
1465, 3eqmA, 0.7999, 3.54, 0.157, 452, 383, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
1466, 1io7B, 0.7999, 2.36, 0.300, 359, 347, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1467, 5veuL, 0.7998, 3.31, 0.207, 448, 376, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1468, 5jl6A, 0.7998, 3.57, 0.148, 452, 384, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
1469, 4wpdA, 0.7998, 2.67, 0.290, 367, 352, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1470, 4gqsD, 0.7998, 3.27, 0.194, 452, 376, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
1471, 3s7sA, 0.7998, 3.54, 0.157, 452, 383, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
1472, 3qu8F, 0.7998, 3.31, 0.162, 453, 377, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
1473, 5em4A, 0.7996, 3.52, 0.165, 460, 381, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1474, 5jkwA, 0.7995, 3.58, 0.148, 452, 384, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
1475, 5jkvA, 0.7995, 3.55, 0.157, 452, 383, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
1476, 4k9wC, 0.7995, 3.32, 0.201, 458, 378, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1477, 4gl5A, 0.7995, 3.55, 0.157, 452, 383, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
1478, 5jl7A, 0.7994, 3.58, 0.148, 452, 384, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
1479, 5em4B, 0.7994, 3.52, 0.165, 459, 381, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
1480, 5e58F, 0.7993, 3.52, 0.160, 457, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1481, 4d78A, 0.7993, 3.35, 0.190, 459, 379, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1482, 5veuK, 0.7991, 3.28, 0.176, 458, 376, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1483, 3nxuA, 0.7991, 3.33, 0.201, 457, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1484, 3nxuB, 0.7990, 3.37, 0.193, 457, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
1485, 4k9wD, 0.7988, 3.38, 0.195, 458, 379, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1486, 4k9wA, 0.7988, 3.42, 0.195, 458, 380, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1487, 3k9yA, 0.7987, 3.64, 0.145, 461, 385, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1488, 4gl7A, 0.7984, 3.56, 0.159, 452, 383, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
1489, 2j0dA, 0.7982, 3.44, 0.175, 446, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1490, 4d7dA, 0.7981, 3.36, 0.188, 458, 378, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
1491, 2rcmA, 0.7980, 3.22, 0.116, 465, 372, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1492, 4mgjA, 0.7971, 3.58, 0.180, 452, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
1493, 2v0mA, 0.7967, 3.38, 0.201, 455, 379, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1494, 3k9vA, 0.7966, 3.71, 0.156, 464, 385, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1495, 3el3B, 0.7965, 3.23, 0.173, 417, 371, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
1496, 3dsjA, 0.7964, 3.41, 0.114, 465, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1497, 4fdhF, 0.7963, 3.69, 0.156, 469, 384, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1498, 2f9qC, 0.7962, 3.59, 0.148, 454, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1499, 3el3A, 0.7961, 3.23, 0.173, 417, 371, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
1500, 4k9wB, 0.7960, 3.37, 0.196, 457, 378, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1501, 3dsiA, 0.7960, 3.41, 0.114, 466, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1502, 4dvqF, 0.7959, 3.71, 0.156, 469, 384, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1503, 4fdhE, 0.7958, 3.52, 0.155, 470, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1504, 3dskA, 0.7958, 3.42, 0.114, 466, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1505, 1w0gA, 0.7958, 3.22, 0.206, 455, 373, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1506, 1f4uB, 0.7957, 2.71, 0.300, 366, 350, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1507, 1f4uA, 0.7957, 2.71, 0.300, 366, 350, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1508, 5hh3A, 0.7955, 3.37, 0.300, 381, 367, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1509, 2rchA, 0.7955, 3.45, 0.114, 465, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1510, 3cliA, 0.7954, 3.46, 0.117, 465, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1511, 2f9qA, 0.7954, 3.62, 0.148, 454, 379, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1512, 2v0mD, 0.7952, 3.39, 0.206, 453, 378, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1513, 2rclA, 0.7952, 3.45, 0.114, 465, 376, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1514, 3kswA, 0.7951, 3.62, 0.172, 444, 384, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
1515, 3k9yB, 0.7951, 3.71, 0.145, 462, 385, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
1516, 4dvqG, 0.7950, 3.76, 0.156, 462, 385, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1517, 4dvqE, 0.7947, 3.58, 0.154, 470, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1518, 4fdhA, 0.7939, 3.62, 0.154, 463, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1519, 4r20A, 0.7936, 3.31, 0.184, 406, 369, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
1520, 2f9qB, 0.7930, 3.61, 0.148, 451, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1521, 4dvqA, 0.7929, 3.57, 0.152, 463, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1522, 3k9vB, 0.7929, 3.76, 0.156, 464, 385, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
1523, 2v0mB, 0.7929, 3.38, 0.207, 451, 377, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
1524, 4zgxC, 0.7928, 3.60, 0.152, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1525, 4fdhG, 0.7928, 3.72, 0.156, 463, 384, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1526, 2vkuA, 0.7927, 3.45, 0.189, 444, 375, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
1527, 4zgxB, 0.7926, 3.59, 0.152, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1528, 2f9qD, 0.7924, 3.63, 0.148, 451, 378, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
1529, 4zgxK, 0.7923, 3.55, 0.161, 461, 380, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1530, 4fdhD, 0.7923, 3.58, 0.152, 465, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1531, 4k9xA, 0.7922, 3.41, 0.198, 449, 374, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1532, 4fdhB, 0.7922, 3.57, 0.152, 465, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1533, 1io9B, 0.7920, 2.45, 0.297, 354, 344, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1534, 4zgxG, 0.7918, 3.61, 0.152, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1535, 4zgxE, 0.7917, 3.63, 0.152, 459, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1536, 4dvqH, 0.7916, 3.55, 0.155, 462, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1537, 4dvqC, 0.7916, 3.65, 0.154, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1538, 4zgxJ, 0.7915, 3.56, 0.155, 463, 380, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1539, 4k9uA, 0.7915, 3.63, 0.202, 450, 377, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
1540, 4dvqB, 0.7913, 3.59, 0.152, 463, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1541, 4zgxA, 0.7911, 3.62, 0.152, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1542, 4zgxL, 0.7907, 3.66, 0.154, 462, 382, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1543, 4fdhC, 0.7907, 3.66, 0.154, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1544, 4zgxD, 0.7906, 3.61, 0.152, 465, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1545, 5hh3C, 0.7905, 3.28, 0.302, 393, 364, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1546, 4dvqJ, 0.7905, 3.67, 0.157, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1547, 4zgxH, 0.7904, 3.68, 0.154, 465, 382, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1548, 4fdhH, 0.7902, 3.61, 0.155, 462, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1549, 4dvqD, 0.7902, 3.67, 0.154, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1550, 4fdhL, 0.7901, 3.60, 0.155, 456, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1551, 4fdhK, 0.7896, 3.58, 0.153, 469, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1552, 4dvqL, 0.7896, 3.58, 0.156, 454, 379, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1553, 4dvqI, 0.7893, 3.68, 0.157, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1554, 2j0dB, 0.7893, 3.48, 0.177, 445, 373, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
1555, 4fdhI, 0.7891, 3.69, 0.154, 462, 382, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1556, 3tjsA, 0.7884, 3.47, 0.210, 449, 376, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
1557, 4zgxF, 0.7883, 3.59, 0.153, 464, 380, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1558, 4dvqK, 0.7882, 3.69, 0.157, 460, 381, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
1559, 5veuE, 0.7881, 3.23, 0.200, 441, 370, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
1560, 4zgxI, 0.7879, 3.71, 0.157, 458, 381, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
1561, 3danA, 0.7878, 3.60, 0.106, 473, 376, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1562, 3psxB, 0.7873, 3.18, 0.148, 414, 365, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1563, 4fdhJ, 0.7868, 3.60, 0.155, 462, 380, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
1564, 3dbmA, 0.7868, 3.61, 0.106, 467, 376, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1565, 3damA, 0.7862, 3.62, 0.109, 467, 376, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
1566, 3dsjB, 0.7853, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
1567, 2rcmB, 0.7853, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
1568, 3dsiB, 0.7851, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
1569, 3dskB, 0.7849, 3.42, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
1570, 2rclB, 0.7846, 3.43, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
1571, 3cliB, 0.7844, 3.44, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
1572, 3psxA, 0.7839, 3.24, 0.151, 412, 364, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
1573, 2rchB, 0.7839, 3.45, 0.105, 465, 371, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
1574, 1w0eA, 0.7839, 3.17, 0.202, 450, 367, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
1575, 1n97A, 0.7824, 3.08, 0.194, 385, 361, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1576, 6bdhA, 0.7814, 3.63, 0.211, 439, 374, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
1577, 1n97B, 0.7786, 3.14, 0.200, 385, 360, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
1578, 3qi8A, 0.7771, 3.27, 0.166, 424, 362, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1579, 4tvfA, 0.7740, 2.47, 0.324, 352, 340, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1580, 4r1zA, 0.7733, 2.96, 0.173, 417, 352, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1581, 2rfcC, 0.7721, 2.27, 0.268, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1582, 2rfcA, 0.7707, 2.31, 0.265, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1583, 2rfcD, 0.7694, 2.31, 0.262, 338, 336, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1584, 2bz9B, 0.7692, 3.44, 0.200, 432, 365, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1585, 1e9xA, 0.7657, 3.94, 0.198, 449, 374, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
1586, 4r1zB, 0.7649, 3.20, 0.169, 411, 354, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
1587, 2w0bA, 0.7622, 3.99, 0.191, 440, 372, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
1588, 1wiyB, 0.7621, 3.25, 0.198, 362, 354, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1589, 3b6hB, 0.7620, 3.96, 0.122, 470, 377, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1590, 2iagB, 0.7619, 3.93, 0.119, 468, 377, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1591, 2bz9A, 0.7611, 3.43, 0.197, 429, 361, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
1592, 3b6hA, 0.7602, 4.12, 0.126, 469, 380, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
1593, 1ea1A, 0.7600, 4.04, 0.188, 447, 373, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
1594, 2iagA, 0.7587, 4.00, 0.122, 471, 377, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
1595, 1x8vA, 0.7571, 3.76, 0.195, 429, 364, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
1596, 2rfbA, 0.7560, 2.60, 0.255, 338, 333, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1597, 2rfcB, 0.7557, 2.52, 0.256, 338, 332, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1598, 3r1bA, 0.7552, 4.07, 0.152, 465, 375, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1599, 1u13A, 0.7548, 3.74, 0.198, 433, 363, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
1600, 3b98A, 0.7538, 4.14, 0.132, 446, 378, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1601, 3b99A, 0.7525, 4.17, 0.132, 445, 378, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1602, 1wiyA, 0.7521, 3.21, 0.203, 358, 349, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1603, 3g5nA, 0.7519, 4.03, 0.143, 456, 371, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1604, 1h5zA, 0.7519, 3.88, 0.192, 434, 364, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
1605, 3g5nB, 0.7512, 4.03, 0.146, 451, 371, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1606, 3r1bB, 0.7511, 4.23, 0.151, 465, 377, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1607, 3r1bD, 0.7510, 4.09, 0.154, 464, 376, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1608, 3g5nC, 0.7503, 3.97, 0.146, 452, 369, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1609, 3g5nD, 0.7498, 4.00, 0.146, 451, 370, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1610, 2rfbB, 0.7479, 2.44, 0.257, 335, 327, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1611, 3daxA, 0.7474, 4.20, 0.129, 472, 379, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1612, 3daxB, 0.7472, 4.16, 0.136, 470, 376, CRYSTAL STRUCTURE OF HUMAN CYP7A1
1613, 3r1bC, 0.7471, 4.24, 0.162, 456, 377, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1614, 2rfbC, 0.7470, 2.53, 0.256, 333, 328, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1615, 3v8dA, 0.7467, 4.21, 0.133, 479, 377, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1616, 2w09A, 0.7453, 3.66, 0.194, 421, 356, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
1617, 3v8dB, 0.7440, 4.30, 0.133, 467, 377, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
1618, 2w0aA, 0.7436, 3.80, 0.195, 424, 359, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
1619, 3g93A, 0.7426, 4.06, 0.144, 454, 368, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1620, 2cibA, 0.7399, 3.69, 0.192, 419, 354, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1621, 3sn5A, 0.7396, 4.19, 0.131, 468, 374, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1622, 3b98B, 0.7396, 4.10, 0.133, 427, 369, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
1623, 1po5A, 0.7391, 4.46, 0.154, 465, 376, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
1624, 2ci0A, 0.7382, 3.77, 0.197, 421, 356, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
1625, 3sn5B, 0.7363, 4.24, 0.120, 466, 375, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
1626, 3g93B, 0.7358, 4.09, 0.148, 442, 365, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1627, 3g93C, 0.7307, 4.14, 0.146, 442, 363, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1628, 3g93D, 0.7304, 4.09, 0.152, 440, 362, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1629, 3dbgB, 0.7284, 2.97, 0.176, 379, 335, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
1630, 3dbgA, 0.7283, 2.97, 0.176, 379, 335, CRYSTAL STRUCTURE OF CYTOCHROME P450 170A1 (CYP170A1) FROM STREPTOMYCES COELICOLOR
1631, 3b99B, 0.7234, 4.19, 0.135, 415, 363, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1632, 2bdmA, 0.7059, 4.80, 0.146, 465, 370, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
1633, 5bv5A, 0.7049, 2.62, 0.290, 315, 310, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1634, 5bv5D, 0.6907, 2.84, 0.289, 327, 308, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1635, 5bv5C, 0.6782, 2.71, 0.298, 311, 299, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1636, 5bv5B, 0.6642, 2.29, 0.300, 288, 287, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1637, 2yjnB, 0.6552, 3.37, 0.237, 337, 304, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1638, 5mnvI, 0.6469, 2.40, 0.389, 286, 285, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
